[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6344 Enrolled Bill (ENR)]
H.R.6344
One Hundred Ninth Congress
of the
United States of America
AT THE SECOND SESSION
Begun and held at the City of Washington on Tuesday,
the third day of January, two thousand and six
An Act
To reauthorize the Office of National Drug Control Policy Act.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE, REFERENCE, AND TABLE OF CONTENTS.
(a) Short Title.--This Act may be cited as the ``Office of National
Drug Control Policy Reauthorization Act of 2006''.
(b) Amendment of Office of National Drug Control Policy
Reauthorization Act of 1998.--Except as otherwise expressly provided,
whenever in this Act an amendment or repeal is expressed in terms of an
amendment to, or repeal of, a section or other provision, the reference
shall be considered to be made to a section or other provision of the
Office of National Drug Control Policy Reauthorization Act of 1998
(Public Law 105-277; 21 U.S.C. 1701 et seq.).
(c) Table of Contents.--The table of contents for this Act is as
follows:
Sec. 1. Short title, reference, and table of contents.
TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND
ROLES AND RESPONSIBILITIES
Sec. 101. Amendments to definitions.
Sec. 102. Establishment of the Office of National Drug Control Policy.
Sec. 103. Appointment and responsibilities of the Director.
Sec. 104. Amendments to ensure coordination with other agencies.
Sec. 105. Budgetary matters.
TITLE II--THE NATIONAL DRUG CONTROL STRATEGY
Sec. 201. Annual preparation and submission of National Drug Control
Strategy.
Sec. 202. Performance measurements.
Sec. 203. Annual report requirement.
TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS
Sec. 301. High Intensity Drug Trafficking Areas Program.
Sec. 302. Funding for certain high intensity drug trafficking areas.
Sec. 303. Assessment.
TITLE IV--TECHNOLOGY
Sec. 401. Counterdrug Technology Assessment Center.
TITLE V--NATIONAL YOUTH MEDIA CAMPAIGN
Sec. 501. National Youth Anti-Drug Media Campaign.
TITLE VI--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE
Sec. 601. Authorization of appropriations.
Sec. 602. Extension of termination date.
TITLE VII--ANTI-DOPING AGENCY
Sec. 701. Designation of United States Anti-Doping Agency.
Sec. 702. Records, audit, and report.
Sec. 703. Authorization of appropriations.
TITLE VIII--DRUG-FREE COMMUNITIES
Sec. 801. Reauthorization.
Sec. 802. Suspension of grants.
Sec. 803. Grant award increase.
Sec. 804. Prohibition on additional eligibility criteria.
Sec. 805. National Community Anti-Drug Coalition Institute.
TITLE IX--NATIONAL GUARD COUNTERDRUG SCHOOLS
Sec. 901. National Guard counterdrug schools.
TITLE X--NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE ACT OF 2006
Sec. 1001. Short title.
Sec. 1002. Definitions.
Sec. 1003. Establishment of clearinghouse and advisory council.
Sec. 1004. NMIC requirements and review.
Sec. 1005. Authorization of appropriations.
TITLE XI--MISCELLANEOUS PROVISIONS
Sec. 1101. Repeals.
Sec. 1102. Controlled Substances Act amendments.
Sec. 1103. Report on law enforcement intelligence sharing.
Sec. 1104. Requirement for South American heroin strategy.
Sec. 1105. Model acts.
Sec. 1106. Study on iatrogenic addiction associated with prescription
opioid analgesic drugs.
Sec. 1107. Requirement for strategy to stop Internet advertising of
prescription medicines without a prescription.
Sec. 1108. Requirement for study on diversion and inappropriate uses of
prescription drugs.
Sec. 1109. Requirement for Afghan Heroin Strategy.
Sec. 1110. Requirement for Southwest Border Counternarcotics Strategy.
Sec. 1111. Requirement for Scientific Study of Mycoherbicide in Illicit
Drug Crop Eradication.
Sec. 1112. Requirement for Study of State Precursor Chemical Control
Laws.
Sec. 1113. Requirement for Study of Drug Endangered Children Programs.
Sec. 1114. Study on drug court hearings in nontraditional places.
Sec. 1115. Report on tribal Government participation in HIDTA process.
Sec. 1116. Report on school drug testing.
Sec. 1117. Report on ONDCP performance bonuses.
Sec. 1118. Requirement for disclosure of Federal sponsorship of all
Federal advertising or other communication materials.
Sec. 1119. Awards for demonstration programs by local partnerships to
coerce abstinence in chronic hard-drug users under community
supervision through the use of drug testing and sanctions.
Sec. 1120. Policy relating to syringe exchange programs.
TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND
ROLES AND RESPONSIBILITIES
SEC. 101. AMENDMENTS TO DEFINITIONS.
(a) Demand Reduction.--Section 702(1) is amended--
(1) in subparagraph (F), by striking ``and'' after the
semicolon;
(2) in paragraph (G), by striking the period at the end and
inserting ``, including the testing of employees;''; and
(3) by adding at the end the following:
``(H) interventions for drug abuse and dependence;
``(I) international drug control coordination and
cooperation with respect to activities described in this
paragraph; and
``(J) international drug abuse education, prevention,
treatment, research, rehabilitation activities, and
interventions for drug abuse and dependence.''.
(b) National Drug Control Program.--Section 702(6) is amended by
adding before the period the following: ``, including any activities
involving supply reduction, demand reduction, or State, local, and
tribal affairs''.
(c) Program Change.--Section 702(7) is amended by--
(1) striking ``National Foreign Intelligence Program,'' and
inserting ``National Intelligence Program,''; and
(2) inserting after ``Related Activities,'' the following: ``or
(for purposes of section 704(d)) an agency that is described in
section 530C(a) of title 28, United States Code,''.
(d) Office.--Section 702(9) is amended by striking ``implicates''
and inserting ``indicates''.
(e) State, Local, and Tribal Affairs.--Paragraph (10) of section
702 is amended to read as follows:
``(10) State, local, and tribal affairs.--The term `State,
local, and tribal affairs' means domestic activities conducted by a
National Drug Control Program agency that are intended to reduce
the availability and use of illegal drugs, including--
``(A) coordination and enhancement of Federal, State,
local, and tribal law enforcement drug control efforts;
``(B) coordination and enhancement of efforts among
National Drug Control Program agencies and State, local, and
tribal demand reduction and supply reduction agencies;
``(C) coordination and enhancement of Federal, State,
local, and tribal law enforcement initiatives to gather,
analyze, and disseminate information and law enforcement
intelligence relating to drug control among domestic law
enforcement agencies; and
``(D) other coordinated and joint initiatives among
Federal, State, local, and tribal agencies to promote
comprehensive drug control strategies designed to reduce the
demand for, and the availability of, illegal drugs.''.
(f) Supply Reduction.--Section 702(11) is amended to read as
follows:
``(11) Supply reduction.--The term `supply reduction' means any
activity or program conducted by a National Drug Control Program
agency that is intended to reduce the availability or use of
illegal drugs in the United States or abroad, including--
``(A) law enforcement outside the United States;
``(B) source country programs, including economic
development programs primarily intended to reduce the
production or trafficking of illicit drugs;
``(C) activities to control international trafficking in,
and availability of, illegal drugs, including--
``(i) accurate assessment and monitoring of
international drug production and interdiction programs and
policies; and
``(ii) coordination and promotion of compliance with
international treaties relating to the production,
transportation, or interdiction of illegal drugs;
``(D) activities to conduct and promote international law
enforcement programs and policies to reduce the supply of
drugs; and
``(E) activities to facilitate and enhance the sharing of
domestic and foreign intelligence information among National
Drug Control Program agencies, relating to the production and
trafficking of drugs in the United States and in foreign
countries.''.
(g) Definitions of Appropriate Congressional Committees and Law
Enforcement.--Section 702 is amended by adding at the end the
following:
``(12) Appropriate congressional committees.--Except where
otherwise provided, the term `appropriate congressional committees'
means the Committee on the Judiciary, the Committee on
Appropriations, and the Caucus on International Narcotics Control
of the Senate and the Committee on Government Reform, the Committee
on the Judiciary, and the Committee on Appropriations of the House
of Representatives.
``(13) Law enforcement.--The term `law enforcement' or `drug
law enforcement' means all efforts by a Federal, State, local, or
tribal government agency to enforce the drug laws of the United
States or any State, including investigation, arrest, prosecution,
and incarceration or other punishments or penalties.''.
SEC. 102. ESTABLISHMENT OF THE OFFICE OF NATIONAL DRUG CONTROL
POLICY.
(a) Responsibilities.--Section 703(a) is amended to read as
follows:
``(a) Establishment of Office.--There is established in the
Executive Office of the President an Office of National Drug Control
Policy, which shall--
``(1) develop national drug control policy;
``(2) coordinate and oversee the implementation of the national
drug control policy;
``(3) assess and certify the adequacy of National Drug Control
Programs and the budget for those programs; and
``(4) evaluate the effectiveness of the national drug control
policy and the National Drug Control Program agencies' programs, by
developing and applying specific goals and performance
measurements.''.
(b) Positions.--Section 703(b) is amended to read as follows:
``(b) Director of National Drug Control Policy and Deputy
Directors.--
``(1) Director.--There shall be a Director of National Drug
Control Policy who shall head the Office (referred to in this Act
as the `Director') and shall hold the same rank and status as the
head of an executive department listed in section 101 of title 5,
United States Code.
``(2) Deputy director.--There shall be a Deputy Director of
National Drug Control Policy who shall report directly to the
Director (referred to in this Act as the `Deputy Director').
``(3) Other deputy directors.--
``(A) In general.--There shall be a Deputy Director for
Demand Reduction, a Deputy Director for Supply Reduction, and a
Deputy Director for State, Local, and Tribal Affairs.
``(B) Reporting.--The Deputy Director for Demand Reduction,
the Deputy Director for Supply Reduction, and the Deputy
Director for State, Local, and Tribal Affairs shall report
directly to the Deputy Director of the Office of National Drug
Control Policy.
``(C) Deputy director for demand reduction.--The Deputy
Director for Demand Reduction shall be responsible for the
activities in subparagraphs (A) through (H) of section 702(l).
``(D) Deputy director for supply reduction.--The Deputy
Director for Supply Reduction shall--
``(i) have substantial experience and expertise in drug
interdiction and other supply reduction activities; and
``(ii) be responsible for the activities in
subparagraphs (A) through (C) in section 702(11).
``(E) Deputy director for state, local, and tribal
affairs.--The Deputy Director for State, Local, and Tribal
Affairs shall be responsible for the activities--
``(i) in subparagraphs (A) through (D) of section
702(10);
``(ii) in section 707, the High Intensity Drug
Trafficking Areas Program; and
``(iii) in section 708, the Counterdrug Technology
Assessment Center.''.
SEC. 103. APPOINTMENT AND RESPONSIBILITIES OF THE DIRECTOR.
(a) Succession.--Section 704(a) is amended by amending paragraph
(3) to read as follows:
``(3) Acting director.--If the Director dies, resigns, or is
otherwise unable to perform the functions and duties of the office,
the Deputy Director shall perform the functions and duties of the
Director temporarily in an acting capacity pursuant to subchapter
III of chapter 33 of title 5, United States Code.''.
(b) Responsibilities.--Section 704(b) is amended--
(1) in paragraph (4), by striking ``Federal departments and
agencies engaged in drug enforcement'' and inserting ``National
Drug Control Program agencies'';
(2) in paragraph (7), by inserting after ``President'' the
following: ``and the appropriate congressional committees'';
(3) in paragraph (13), by striking ``(beginning in 1999)'';
(4) by striking paragraph (14) and inserting the following:
``(14) shall submit to the appropriate congressional committees
on an annual basis, not later than 60 days after the date of the
last day of the applicable period, a summary of--
``(A) each of the evaluations received by the Director
under paragraph (13); and
``(B) the progress of each National Drug Control Program
agency toward the drug control program goals of the agency
using the performance measures for the agency developed under
section 706(c);'';
(5) in paragraph (15), by striking subparagraph (C) and
inserting the following:
``(C) supporting the substance abuse information
clearinghouse administered by the Administrator of the
Substance Abuse and Mental Health Services Administration and
established in section 501(d)(16) of the Public Health Service
Act by--
``(i) encouraging all National Drug Control Program
agencies to provide all appropriate and relevant
information; and
``(ii) supporting the dissemination of information to
all interested entities;''; and
(6) by inserting at the end the following:
``(16) shall coordinate with the private sector to promote
private research and development of medications to treat addiction;
``(17) shall seek the support and commitment of State, local,
and tribal officials in the formulation and implementation of the
National Drug Control Strategy;
``(18) shall monitor and evaluate the allocation of resources
among Federal law enforcement agencies in response to significant
local and regional drug trafficking and production threats;
``(19) shall submit an annual report to Congress detailing how
the Office of National Drug Control Policy has consulted with and
assisted State, local, and tribal governments with respect to the
formulation and implementation of the National Drug Control
Strategy and other relevant issues; and
``(20) shall, within 1 year after the date of the enactment of
the Office of National Drug Control Policy Reauthorization Act of
2006, report to Congress on the impact of each Federal drug
reduction strategy upon the availability, addiction rate, use rate,
and other harms of illegal drugs.''.
(c) Review and Certification of National Drug Control Program
Budget.--Section 704(c)(3) is amended--
(1) in subparagraph (C)(iii), by inserting ``and the
appropriate congressional committees,'' after ``House of
Representatives''; and
(2) in subparagraph (D)(ii)(II)(bb), by inserting ``and the
appropriate congressional committees,'' after ``House of
Representatives''.
(d) Powers of Director.--Section 704(d) is amended--
(1) in paragraph (9), by striking ``Strategy; and'' and
inserting ``Strategy and notify the appropriate congressional
committees of any fund control notice issued in accordance with
section 704(f)(5);''; and
(2) in paragraph (10), by inserting before the period the
following: ``and section 706 of the Department of State
Authorization Act for Fiscal Year 2003 (22 U.S.C. 229j-1)''.
(e) Fund Control Notices.--Section 704(f) is amended by adding at
the end the following:
``(4) Congressional notice.--A copy of each fund control notice
shall be transmitted to the appropriate congressional committees.
``(5) Restrictions.--The Director shall not issue a fund
control notice to direct that all or part of an amount appropriated
to the National Drug Control Program agency account be obligated,
modified, or altered in any manner--
``(A) contrary, in whole or in part, to a specific
appropriation; or
``(B) contrary, in whole or in part, to the expressed
intent of Congress.''.
(f) Drug Interdiction.--
(1) In general.--Section 711 is amended by adding at the end
the following:
``SEC. 711. DRUG INTERDICTION COORDINATOR AND COMMITTEE.
``(a) United States Interdiction Coordinator.--
``(1) In general.--The United States Interdiction Coordinator
shall perform the duties of that position described in paragraph
(2) and such other duties as may be determined by the Director with
respect to coordination of efforts to interdict illicit drugs from
entering the United States.
``(2) Responsibilities.--The United States Interdiction
Coordinator shall be responsible to the Director for--
``(A) coordinating the interdiction activities of the
National Drug Control Program agencies to ensure consistency
with the National Drug Control Strategy;
``(B) on behalf of the Director, developing and issuing, on
or before March 1 of each year and in accordance with paragraph
(3), a National Interdiction Command and Control Plan to ensure
the coordination and consistency described in subparagraph (A);
``(C) assessing the sufficiency of assets committed to
illicit drug interdiction by the relevant National Drug Control
Program agencies; and
``(D) advising the Director on the efforts of each National
Drug Control Program agency to implement the National
Interdiction Command and Control Plan.
``(3) Staff.--The Director shall assign such permanent staff of
the Office as he considers appropriate to assist the United States
Interdiction Coordinator to carry out the responsibilities
described in paragraph (2), and may also, at his discretion,
request that appropriate National Drug Control Program agencies
detail or assign staff to the Office of Supply Reduction for that
purpose.
``(4) National interdiction command and control plan.--
``(A) Purposes.--The National Interdiction Command and
Control Plan shall--
``(i) set forth the Government's strategy for drug
interdiction;
``(ii) state the specific roles and responsibilities of
the relevant National Drug Control Program agencies for
implementing that strategy; and
``(iii) identify the specific resources required to
enable the relevant National Drug Control Program agencies
to implement that strategy.
``(B) Consultation with other agencies.--The United States
Interdiction Coordinator shall issue the National Interdiction
Command and Control Plan in consultation with the other members
of the Interdiction Committee described in subsection (b).
``(C) Limitation.--The National Interdiction Command and
Control Plan shall not change existing agency authorities or
the laws governing interagency relationships, but may include
recommendations about changes to such authorities or laws.
``(D) Report to congress.--On or before March 1 of each
year, the United States Interdiction Coordinator shall provide
a report on behalf of the Director to the appropriate
congressional committees, to the Committee on Armed Services
and the Committee on Homeland Security of the House of
Representatives, and to the Committee on Homeland Security and
Governmental Affairs and the Committee on Armed Services of the
Senate, which shall include--
``(i) a copy of that year's National Interdiction
Command and Control Plan;
``(ii) information for the previous 10 years regarding
the number and type of seizures of drugs by each National
Drug Control Program agency conducting drug interdiction
activities, as well as statistical information on the
geographic areas of such seizures; and
``(iii) information for the previous 10 years regarding
the number of air and maritime patrol hours undertaken by
each National Drug Control Program agency conducting drug
interdiction activities, as well as statistical information
on the geographic areas in which such patrol hours took
place.
``(E) Treatment of classified or law enforcement sensitive
information.--Any content of the report described in
subparagraph (D) that involves information classified under
criteria established by an Executive order, or the public
disclosure of which, as determined by the Director, the
Director of National Intelligence, or the head of any Federal
Government agency the activities of which are described in the
plan, would be detrimental to the law enforcement or national
security activities of any Federal, State, or local agency,
shall be presented to Congress separately from the rest of the
report.
``(b) Interdiction Committee.--
``(1) In general.--The Interdiction Committee shall meet to--
``(A) discuss and resolve issues related to the
coordination, oversight and integration of international,
border, and domestic drug interdiction efforts in support of
the National Drug Control Strategy;
``(B) review the annual National Interdiction Command and
Control Plan, and provide advice to the Director and the United
States Interdiction Coordinator concerning that plan; and
``(C) provide such other advice to the Director concerning
drug interdiction strategy and policies as the committee
determines is appropriate.
``(2) Chairman.--The Director shall designate one of the
members of the Interdiction Committee to serve as chairman.
``(3) Meetings.--The members of the Interdiction Committee
shall meet, in person and not through any delegate or
representative, at least once per calendar year, prior to March 1.
At the call of either the Director or the current chairman, the
Interdiction Committee may hold additional meetings, which shall be
attended by the members either in person, or through such delegates
or representatives as they may choose.
``(4) Report.--Not later than September 30 of each year, the
chairman of the Interdiction Committee shall submit a report to the
Director and to the appropriate congressional committees describing
the results of the meetings and any significant findings of the
Committee during the previous 12 months. Any content of such a
report that involves information classified under criteria
established by an Executive order, or whose public disclosure, as
determined by the Director, the chairman, or any member, would be
detrimental to the law enforcement or national security activities
of any Federal, State, local, or tribal agency, shall be presented
to Congress separately from the rest of the report.''.
(2) Conforming amendment to homeland security act of 2002.--
Section 878 of the Homeland Security Act of 2002 (6 U.S.C. 458) is
amended--
(A) in subsection (c), by striking ``Except as provided in
subsection (d), the'' and inserting ``The''; and
(B) by striking subsection (d) and redesignating
subsections (e), (f), and (g) as subsections (d), (e), and (f),
respectively.
(3) Technical amendments.--Section 704 (21 U.S.C. 1703) is
amended--
(A) by amending subsection (g) to read as follows:
``(g) Inapplicability to Certain Programs.--The provisions of this
section shall not apply to the National Intelligence Program, the Joint
Military Intelligence Program, and Tactical and Related Activities,
unless such program or an element of such program is designated as a
National Drug Control Program--
``(1) by the President; or
``(2) jointly by--
``(A) in the case of the National Intelligence Program, the
Director and the Director of National Intelligence; or
``(B) in the case of the Joint Military Intelligence
Program and Tactical and Related Activities, the Director, the
Director of National Intelligence, and the Secretary of
Defense.''; and
(B) by amending subsection (h) to read as follows:
``(h) Construction.--Nothing in this Act shall be construed as
derogating the authorities and responsibilities of the Director of
National Intelligence or the Director of the Central Intelligence
Agency contained in the National Security Act of 1947 (50 U.S.C. 401 et
seq.), the Central Intelligence Agency Act of 1949 (50 U.S.C. 403a et
seq.), or any other law.''.
SEC. 104. AMENDMENTS TO ENSURE COORDINATION WITH OTHER AGENCIES.
Section 705 is amended--
(1) in subsection (a)(1)(A), by striking ``abuse'';
(2) in subsection (a)(2)(A), by striking ``Director of Central
Intelligence'' and inserting ``Director of National Intelligence'';
(3) in subsection (a)(2)(B), by striking ``Director of Central
Intelligence'' and inserting ``Director of National Intelligence
and the Director of the Central Intelligence Agency'';
(4) by amending subsection (a)(3) to read as follows:
``(3) Required reports.--
``(A) Secretaries of the interior and agriculture.--Not
later than July 1 of each year, the Secretaries of Agriculture
and the Interior shall jointly submit to the Director and the
appropriate congressional committees an assessment of the
quantity of illegal drug cultivation and manufacturing in the
United States on lands owned or under the jurisdiction of the
Federal Government for the preceding year.
``(B) Secretary of homeland security.--Not later than July
1 of each year, the Secretary of Homeland Security shall submit
to the Director and the appropriate congressional committees
information for the preceding year regarding--
``(i) the number and type of seizures of drugs by each
component of the Department of Homeland Security seizing
drugs, as well as statistical information on the geographic
areas of such seizures; and
``(ii) the number of air and maritime patrol hours
primarily dedicated to drug supply reduction missions
undertaken by each component of the Department of Homeland
Security.
``(C) Secretary of defense.--The Secretary of Defense
shall, by July 1 of each year, submit to the Director and the
appropriate congressional committees information for the
preceding year regarding the number of air and maritime patrol
hours primarily dedicated to drug supply reduction missions
undertaken by each component of the Department of Defense.
``(D) Attorney general.--The Attorney General shall, by
July 1 of each year, submit to the Director and the appropriate
congressional committees information for the preceding year
regarding the number and type of--
``(i) arrests for drug violations;
``(ii) prosecutions for drug violations by United
States Attorneys; and
``(iii) seizures of drugs by each component of the
Department of Justice seizing drugs, as well as statistical
information on the geographic areas of such seizures.'';
(5) in subsection (b)(2)(B), by striking ``Program'' and
inserting ``Strategy''; and
(6) in subsection (c), by striking ``in'' and inserting ``on''.
SEC. 105. BUDGETARY MATTERS.
(a) Submission of Drug Control Budget Requests.--Section 704(c)(1)
is amended by adding at the end the following:
``(C) Content of drug control budget requests.--A drug
control budget request submitted by a department, agency, or
program under this paragraph shall include all requests for
funds for any drug control activity undertaken by that
department, agency, or program, including demand reduction,
supply reduction, and State, local, and tribal affairs,
including any drug law enforcement activities. If an activity
has both drug control and nondrug control purposes or
applications, the department, agency, or program shall estimate
by a documented calculation the total funds requested for that
activity that would be used for drug control, and shall set
forth in its request the basis and method for making the
estimate.''.
(b) National Drug Control Budget Proposal.--
(1) National organizations.--Section 704(c)(2) is amended by
inserting ``and the head of each major national organization that
represents law enforcement officers, agencies, or associations''
after ``agency''.
(2) Total budget.--Section 704(c)(2)(A) is amended by inserting
before the semicolon: ``and to inform Congress and the public about
the total amount proposed to be spent on all supply reduction,
demand reduction, State, local, and tribal affairs, including any
drug law enforcement, and other drug control activities by the
Federal Government, which shall conform to the content requirements
set forth in paragraph (1)(C)''.
(c) Review and Certification of National Drug Control Program
Budget.--Section 704(c)(3) is amended--
(1) by redesignating subparagraphs (C) and (D) as subparagraphs
(D) and (E), respectively;
(2) by inserting after subparagraph (B) the following new
subparagraph:
``(C) Specific requests.--The Director shall not confirm
the adequacy of any budget request that--
``(i) requests funding for Federal law enforcement
activities that do not adequately compensate for transfers
of drug enforcement resources and personnel to law
enforcement and investigation activities;
``(ii) requests funding for law enforcement activities
on the borders of the United States that do not adequately
direct resources to drug interdiction and enforcement;
``(iii) requests funding for drug treatment activities
that do not provide adequate results and accountability
measures;
``(iv) requests funding for any activities of the Safe
and Drug-Free Schools Program that do not include a clear
anti-drug message or purpose intended to reduce drug use;
``(v) requests funding for drug treatment activities
that do not adequately support and enhance Federal drug
treatment programs and capacity;
``(vi) requests funding for fiscal year 2007 for
activities of the Department of Education, unless it is
accompanied by a report setting forth a plan for providing
expedited consideration of student loan applications for
all individuals who submitted an application for any
Federal grant, loan, or work assistance that was rejected
or denied pursuant to 484(r)(1) of the Higher Education Act
of 1965 (20 U.S.C. 1091(r)(1)) by reason of a conviction
for a drug-related offense not occurring during a period of
enrollment for which the individual was receiving any
Federal grant, loan, or work assistance; and
``(vii) requests funding for the operations and
management of the Department of Homeland Security that does
not include a specific request for funds for the Office of
Counternarcotics Enforcement to carry out its
responsibilities under section 878 of the Homeland Security
Act of 2002 (6 U.S.C. 458).'';
(3) in subparagraph (D)(iii), as so redesignated, by inserting
``and the appropriate congressional committees'' after ``House of
Representatives''; and
(4) in subparagraph (E)(ii)(II)(bb), as so redesignated, by
inserting ``and the appropriate congressional committees'' after
``House of Representatives''.
(d) Reprogramming and Transfer Requests.--Section 704(c)(4)(A) (21
U.S.C. 1703(c)(4)(A)) is amended--
(1) by striking ``$5,000,000'' and inserting ``$1,000,000'';
and
(2) adding at the end the following: ``If the Director has not
responded to a request for reprogramming subject to this
subparagraph within 30 days after receiving notice of the request
having been made, the request shall be deemed approved by the
Director under this subparagraph and forwarded to Congress.''.
(e) Powers of Director.--Section 704(d) is amended--
(1) in paragraph (8)(D), by striking ``have been authorized by
Congress;'' and inserting ``authorized by law;'';
(2) in paragraph (9), by striking ``Strategy; and'' and
inserting ``Strategy and notify the appropriate congressional
committees of any fund control notice issued; and''; and
(3) in paragraph (10), by striking ``(22 U.S.C. 2291j).'' and
inserting ``(22 U.S.C. 2291j) and section 706 of the Foreign
Relations Authorization Act, Fiscal Year 2003 (22 U.S.C. 2291j-
1).''.
(f) Fund Control Notices.--Section 704(f) (21 U.S.C. 1703(f)) is
amended by adding at the end the following:
``(4) Congressional notice.--A copy of each fund control notice
shall be transmitted to the appropriate congressional committees.
``(5) Restrictions.--The Director shall not issue a fund
control notice to direct that all or part of an amount appropriated
to the National Drug Control Program agency account be obligated,
modified, or altered in any manner contrary, in whole or in part,
to a specific appropriation or statute.''.
TITLE II--THE NATIONAL DRUG CONTROL STRATEGY
SEC. 201. ANNUAL PREPARATION AND SUBMISSION OF NATIONAL DRUG
CONTROL STRATEGY.
Section 706 is amended to read as follows:
``SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, AND ASSESSMENT
OF NATIONAL DRUG CONTROL STRATEGY.
``(a) Timing, Contents, and Process for Development and Submission
of National Drug Control Strategy.--
``(1) Timing.--Not later than February 1 of each year, the
President shall submit to Congress a National Drug Control
Strategy, which shall set forth a comprehensive plan for the year
to reduce illicit drug use and the consequences of such illicit
drug use in the United States by limiting the availability of, and
reducing the demand for, illegal drugs.
``(2) Contents.--
``(A) In general.--The National Drug Control Strategy
submitted under paragraph (1) shall include the following:
``(i) Comprehensive, research-based, long-range,
quantifiable goals for reducing illicit drug use and the
consequences of illicit drug use in the United States.
``(ii) Annual quantifiable and measurable objectives
and specific targets to accomplish long-term quantifiable
goals that the Director determines may be achieved during
each year beginning on the date on which the National Drug
Control Strategy is submitted.
``(iii) A 5-year projection for program and budget
priorities.
``(iv) A review of international, State, local, and
private sector drug control activities to ensure that the
United States pursues coordinated and effective drug
control at all levels of government.
``(v) An assessment of current illicit drug use
(including inhalants and steroids) and availability, impact
of illicit drug use, and treatment availability, which
assessment shall include--
``(I) estimates of drug prevalence and frequency of
use as measured by national, State, and local surveys
of illicit drug use and by other special studies of
nondependent and dependent illicit drug use;
``(II) illicit drug use in the workplace and the
productivity lost by such use; and
``(III) illicit drug use by arrestees,
probationers, and parolees.
``(vi) An assessment of the reduction of illicit drug
availability, as measured by--
``(I) the quantities of cocaine, heroin, marijuana,
methamphetamine, ecstasy, and other drugs available for
consumption in the United States;
``(II) the amount of marijuana, cocaine, heroin,
methamphetamine, ecstasy, and precursor chemicals and
other drugs entering the United States;
``(III) the number of illicit drug manufacturing
laboratories seized and destroyed and the number of
hectares of marijuana, poppy, and coca cultivated and
destroyed domestically and in other countries;
``(IV) the number of metric tons of marijuana,
heroin, cocaine, and methamphetamine seized and other
drugs; and
``(V) changes in the price and purity of heroin,
methamphetamine, and cocaine, changes in the price of
ecstasy, and changes in tetrahydrocannabinol level of
marijuana and other drugs.
``(vii) An assessment of the reduction of the
consequences of illicit drug use and availability, which
shall include--
``(I) the burden illicit drug users placed on
hospital emergency departments in the United States,
such as the quantity of illicit drug-related services
provided;
``(II) the annual national health care cost of
illicit drug use; and
``(III) the extent of illicit drug-related crime
and criminal activity.
``(viii) A determination of the status of drug
treatment in the United States, by assessing--
``(I) public and private treatment utilization; and
``(II) the number of illicit drug users the
Director estimates meet diagnostic criteria for
treatment.
``(ix) A review of the research agenda of the
Counterdrug Technology Assessment Center to reduce the
availability and abuse of drugs.
``(x) A summary of the efforts made to coordinate with
private sector entities to conduct private research and
development of medications to treat addiction by--
``(I) screening chemicals for potential therapeutic
value;
``(II) developing promising compounds;
``(III) conducting clinical trials;
``(IV) seeking Food and Drug Administration
approval for drugs to treat addiction;
``(V) marketing the drug for the treatment of
addiction;
``(VI) urging physicians to use the drug in the
treatment of addiction; and
``(VII) encouraging insurance companies to
reimburse the cost of the drug for the treatment of
addiction.
``(xi) An assessment of Federal effectiveness in
achieving the National Drug Control Strategy for the
previous year, including a specific evaluation of whether
the objectives and targets for reducing illicit drug use
for the previous year were met and reasons for the success
or failure of the previous year's Strategy.
``(xii) A general review of the status of, and trends
in, demand reduction activities by private sector entities
and community-based organizations, including faith-based
organizations, to determine their effectiveness and the
extent of cooperation, coordination, and mutual support
between such entities and organizations and Federal, State,
local, and tribal government agencies.
``(xiii) Such additional statistical data and
information as the Director considers appropriate to
demonstrate and assess trends relating to illicit drug use,
the effects and consequences of illicit drug use (including
the effects on children of substance abusers), supply
reduction, demand reduction, drug-related law enforcement,
and the implementation of the National Drug Control
Strategy.
``(xiv) A supplement reviewing the activities of each
individual National Drug Control Program agency during the
previous year with respect to the National Drug Control
Strategy and the Director's assessment of the progress of
each National Drug Control Program agency in meeting its
responsibilities under the National Drug Control Strategy.
``(B) Classified information.--Any contents of the National
Drug Control Strategy that involve information properly
classified under criteria established by an Executive order
shall be presented to Congress separately from the rest of the
National Drug Control Strategy.
``(C) Selection of data and information.--In selecting data
and information for inclusion under subparagraph (A), the
Director shall ensure--
``(i) the inclusion of data and information that will
permit analysis of current trends against previously
compiled data and information where the Director believes
such analysis enhances long-term assessment of the National
Drug Control Strategy; and
``(ii) the inclusion of data and information to permit
a standardized and uniform assessment of the effectiveness
of drug treatment programs in the United States.
``(3) Process for development and submission.--In developing
and effectively implementing the National Drug Control Strategy,
the Director--
``(A) shall consult with--
``(i) the heads of the National Drug Control Program
agencies;
``(ii) Congress;
``(iii) State, local, and tribal officials;
``(iv) private citizens and organizations, including
community and faith-based organizations with experience and
expertise in demand reduction;
``(v) private citizens and organizations with
experience and expertise in supply reduction; and
``(vi) appropriate representatives of foreign
governments;
``(B) in satisfying the requirements of subparagraph (A),
shall ensure, to the maximum extent possible, that State,
local, and tribal officials and relevant private organizations
commit to support and take steps to achieve the goals and
objectives of the National Drug Control Strategy;
``(C) with the concurrence of the Attorney General, may
require the El Paso Intelligence Center to undertake specific
tasks or projects to support or implement the National Drug
Control Strategy; and
``(D) with the concurrence of the Director of National
Intelligence and the Attorney General, may request that the
National Drug Intelligence Center undertake specific tasks or
projects to support or implement the National Drug Control
Strategy.
``(b) Submission of Revised Strategy.--The President may submit to
Congress a revised National Drug Control Strategy that meets the
requirements of this section--
``(1) at any time, upon a determination of the President, in
consultation with the Director, that the National Drug Control
Strategy in effect is not sufficiently effective; or
``(2) if a new President or Director takes office.''.
SEC. 202. PERFORMANCE MEASUREMENTS.
Section 706 is amended by adding at the end the following:
``(c) Performance Measurement System.--Not later than February 1 of
each year, the Director shall submit to Congress as part of the
National Drug Control Strategy, a description of a national drug
control performance measurement system, that--
``(1) develops 2-year and 5-year performance measures and
targets for each National Drug Control Strategy goal and objective
established for reducing drug use, availability, and the
consequences of drug use;
``(2) describes the sources of information and data that will
be used for each performance measure incorporated into the
performance measurement system;
``(3) identifies major programs and activities of the National
Drug Control Program agencies that support the goals and annual
objectives of the National Drug Control Strategy;
``(4) evaluates the contribution of demand reduction and supply
reduction activities as defined in section 702 implemented by each
National Drug Control Program agency in support of the National
Drug Control Strategy;
``(5) monitors consistency between the drug-related goals and
objectives of the National Drug Control Program agencies and
ensures that each agency's goals and budgets support and are fully
consistent with the National Drug Control Strategy; and
``(6) coordinates the development and implementation of
national drug control data collection and reporting systems to
support policy formulation and performance measurement, including
an assessment of--
``(A) the quality of current drug use measurement
instruments and techniques to measure supply reduction and
demand reduction activities;
``(B) the adequacy of the coverage of existing national
drug use measurement instruments and techniques to measure the
illicit drug user population, and groups that are at risk for
illicit drug use;
``(C) the adequacy of the coverage of existing national
treatment outcome monitoring systems to measure the
effectiveness of drug abuse treatment in reducing illicit drug
use and criminal behavior during and after the completion of
substance abuse treatment; and
``(D) the actions the Director shall take to correct any
deficiencies and limitations identified pursuant to
subparagraphs (A) and (B) of this subsection.
``(d) Modifications.--A description of any modifications made
during the preceding year to the national drug performance measurement
system described in subsection (c) shall be included in each report
submitted under subsection (b).''.
SEC. 203. ANNUAL REPORT REQUIREMENT.
(a) In General.--On or before February 1 of each year, the Director
shall submit a report to Congress that describes--
(1) the strategy of the national media campaign and whether
specific objectives of the campaign were accomplished;
(2) steps taken to ensure that the national media campaign
operates in an effective and efficient manner consistent with the
overall strategy and focus of the campaign;
(3) plans to purchase advertising time and space;
(4) policies and practices implemented to ensure that Federal
funds are used responsibly to purchase advertising time and space
and eliminate the potential for waste, fraud, and abuse;
(5) all contracts entered into with a corporation, partnership,
or individual working on behalf of the national media campaign;
(6) specific policies and steps implemented to ensure
compliance with title IV of this Act;
(7) steps taken to ensure that the national media campaign will
secure, to the maximum extent possible, no cost matches of
advertising time and space or in-kind contributions that are
directly related to the campaign in accordance with title IV of
this Act; and
(8) a review and evaluation of the effectiveness of the
national media campaign strategy for the past year.
(b) Audit.--The Government Accountability Office shall, at a
frequency of not less than once per year--
(1) conduct and supervise an audit and investigation relating
to the programs and operations of the--
(A) Office; or
(B) certain programs within the Office, including--
(i) the High Intensity Drug Trafficking Areas Program;
(ii) the Counterdrug Technology Assessment Center; or
(iii) the National Youth Anti-drug Media Campaign; and
(2) provide the Director and the appropriate congressional
committees with a report containing an evaluation of and
recommendations on the--
(A) policies and activities of the programs and operations
subject to the audit and investigation;
(B) economy, efficiency, and effectiveness in the
administration of the reviewed programs and operations; and
(C) policy or management changes needed to prevent and
detect fraud and abuse in such programs and operations.
TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS
SEC. 301. HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.
Section 707 is amended to read as follows:
``SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.
``(a) Establishment.--
``(1) In general.--There is established in the Office a program
to be known as the High Intensity Drug Trafficking Areas Program
(in this section referred to as the `Program').
``(2) Purpose.--The purpose of the Program is to reduce drug
trafficking and drug production in the United States by--
``(A) facilitating cooperation among Federal, State, local,
and tribal law enforcement agencies to share information and
implement coordinated enforcement activities;
``(B) enhancing law enforcement intelligence sharing among
Federal, State, local, and tribal law enforcement agencies;
``(C) providing reliable law enforcement intelligence to
law enforcement agencies needed to design effective enforcement
strategies and operations; and
``(D) supporting coordinated law enforcement strategies
which maximize use of available resources to reduce the supply
of illegal drugs in designated areas and in the United States
as a whole.
``(b) Designation.--
``(1) In general.--The Director, in consultation with the
Attorney General, the Secretary of the Treasury, the Secretary of
Homeland Security, heads of the National Drug Control Program
agencies, and the Governor of each applicable State, may designate
any specified area of the United States as a high intensity drug
trafficking area.
``(2) Activities.--After making a designation under paragraph
(1) and in order to provide Federal assistance to the area so
designated, the Director may--
``(A) obligate such sums as are appropriated for the
Program;
``(B) direct the temporary reassignment of Federal
personnel to such area, subject to the approval of the head of
the department or agency that employs such personnel;
``(C) take any other action authorized under section 704 to
provide increased Federal assistance to those areas; and
``(D) coordinate activities under this section
(specifically administrative, recordkeeping, and funds
management activities) with State, local, and tribal officials.
``(c) Petitions for Designation.--The Director shall establish
regulations under which a coalition of interested law enforcement
agencies from an area may petition for designation as a high intensity
drug trafficking area. Such regulations shall provide for a regular
review by the Director of the petition, including a recommendation
regarding the merit of the petition to the Director by a panel of
qualified, independent experts.
``(d) Factors for Consideration.--In considering whether to
designate an area under this section as a high intensity drug
trafficking area, the Director shall consider, in addition to such
other criteria as the Director considers to be appropriate, the extent
to which--
``(1) the area is a significant center of illegal drug
production, manufacturing, importation, or distribution;
``(2) State, local, and tribal law enforcement agencies have
committed resources to respond to the drug trafficking problem in
the area, thereby indicating a determination to respond
aggressively to the problem;
``(3) drug-related activities in the area are having a
significant harmful impact in the area, and in other areas of the
country; and
``(4) a significant increase in allocation of Federal resources
is necessary to respond adequately to drug-related activities in
the area.
``(e) Organization of High Intensity Drug Trafficking Areas.--
``(1) Executive board and officers.--To be eligible for funds
appropriated under this section, each high intensity drug
trafficking area shall be governed by an Executive Board. The
Executive Board shall designate a chairman, vice chairman, and any
other officers to the Executive Board that it determines are
necessary.
``(2) Responsibilities.--The Executive Board of a high
intensity drug trafficking area shall be responsible for--
``(A) providing direction and oversight in establishing and
achieving the goals of the high intensity drug trafficking
area;
``(B) managing the funds of the high intensity drug
trafficking area;
``(C) reviewing and approving all funding proposals
consistent with the overall objective of the high intensity
drug trafficking area; and
``(D) reviewing and approving all reports to the Director
on the activities of the high intensity drug trafficking area.
``(3) Board representation.--None of the funds appropriated
under this section may be expended for any high intensity drug
trafficking area, or for a partnership or region of a high
intensity drug trafficking area, if the Executive Board for such
area, region, or partnership, does not apportion an equal number of
votes between representatives of participating Federal agencies and
representatives of participating State, local, and tribal agencies.
Where it is impractical for an equal number of representatives of
Federal agencies and State, local, and tribal agencies to attend a
meeting of an Executive Board in person, the Executive Board may
use a system of proxy votes or weighted votes to achieve the voting
balance required by this paragraph.
``(4) No agency relationship.--The eligibility requirements of
this section are intended to ensure the responsible use of Federal
funds. Nothing in this section is intended to create an agency
relationship between individual high intensity drug trafficking
areas and the Federal Government.
``(f) Use of Funds.--The Director shall ensure that no Federal
funds appropriated for the Program are expended for the establishment
or expansion of drug treatment programs, and shall ensure that not more
than 5 percent of the Federal funds appropriated for the Program are
expended for the establishment of drug prevention programs.
``(g) Counterterrorism Activities.--
``(1) Assistance authorized.--The Director may authorize use of
resources available for the Program to assist Federal, State,
local, and tribal law enforcement agencies in investigations and
activities related to terrorism and prevention of terrorism,
especially but not exclusively with respect to such investigations
and activities that are also related to drug trafficking.
``(2) Limitation.--The Director shall ensure--
``(A) that assistance provided under paragraph (1) remains
incidental to the purpose of the Program to reduce drug
availability and carry out drug-related law enforcement
activities; and
``(B) that significant resources of the Program are not
redirected to activities exclusively related to terrorism,
except on a temporary basis under extraordinary circumstances,
as determined by the Director.
``(h) Role of Drug Enforcement Administration.--The Director, in
consultation with the Attorney General, shall ensure that a
representative of the Drug Enforcement Administration is included in
the Intelligence Support Center for each high intensity drug
trafficking area.
``(i) Annual HIDTA Program Budget Submissions.--As part of the
documentation that supports the President's annual budget request for
the Office, the Director shall submit to Congress a budget
justification that includes--
``(1) the amount proposed for each high intensity drug
trafficking area, conditional upon a review by the Office of the
request submitted by the HIDTA and the performance of the HIDTA,
with supporting narrative descriptions and rationale for each
request;
``(2) a detailed justification that explains--
``(A) the reasons for the proposed funding level; how such
funding level was determined based on a current assessment of
the drug trafficking threat in each high intensity drug
trafficking area;
``(B) how such funding will ensure that the goals and
objectives of each such area will be achieved; and
``(C) how such funding supports the National Drug Control
Strategy; and
``(3) the amount of HIDTA funds used to investigate and
prosecute organizations and individuals trafficking in
methamphetamine in the prior calendar year, and a description of
how those funds were used.
``(j) Emerging Threat Response Fund.--
``(1) In general.--Subject to the availability of
appropriations, the Director may expend up to 10 percent of the
amounts appropriated under this section on a discretionary basis,
to respond to any emerging drug trafficking threat in an existing
high intensity drug trafficking area, or to establish a new high
intensity drug trafficking area or expand an existing high
intensity drug trafficking area, in accordance with the criteria
established under paragraph (2).
``(2) Consideration of impact.--In allocating funds under this
subsection, the Director shall consider--
``(A) the impact of activities funded on reducing overall
drug traffic in the United States, or minimizing the
probability that an emerging drug trafficking threat will
spread to other areas of the United States; and
``(B) such other criteria as the Director considers
appropriate.
``(k) Evaluation.--
``(1) Initial report.--Not later than 90 days after the date of
the enactment of this section, the Director shall, after consulting
with the Executive Boards of each designated high intensity drug
trafficking area, submit a report to Congress that describes, for
each designated high intensity drug trafficking area--
``(A) the specific purposes for the high intensity drug
trafficking area;
``(B) the specific long-term and short-term goals and
objectives for the high intensity drug trafficking area;
``(C) the measurements that will be used to evaluate the
performance of the high intensity drug trafficking area in
achieving the long-term and short-term goals; and
``(D) the reporting requirements needed to evaluate the
performance of the high intensity drug trafficking area in
achieving the long-term and short-term goals.
``(2) Evaluation of hidta program as part of national drug
control strategy.--For each designated high intensity drug
trafficking area, the Director shall submit, as part of the annual
National Drug Control Strategy report, a report that--
``(A) describes--
``(i) the specific purposes for the high intensity drug
trafficking area; and
``(ii) the specific long-term and short-term goals and
objectives for the high intensity drug trafficking area;
and
``(B) includes an evaluation of the performance of the high
intensity drug trafficking area in accomplishing the specific
long-term and short-term goals and objectives identified under
paragraph (1)(B).
``(l) Assessment of Drug Enforcement Task Forces in High Intensity
Drug Trafficking Areas.--Not later than 1 year after the date of
enactment of this subsection, and as part of each subsequent annual
National Drug Control Strategy report, the Director shall submit to
Congress a report--
``(1) assessing the number and operation of all federally
funded drug enforcement task forces within each high intensity drug
trafficking area; and
``(2) describing--
``(A) each Federal, State, local, and tribal drug
enforcement task force operating in the high intensity drug
trafficking area;
``(B) how such task forces coordinate with each other, with
any high intensity drug trafficking area task force, and with
investigations receiving funds from the Organized Crime and
Drug Enforcement Task Force;
``(C) what steps, if any, each such task force takes to
share information regarding drug trafficking and drug
production with other federally funded drug enforcement task
forces in the high intensity drug trafficking area;
``(D) the role of the high intensity drug trafficking area
in coordinating the sharing of such information among task
forces;
``(E) the nature and extent of cooperation by each Federal,
State, local, and tribal participant in ensuring that such
information is shared among law enforcement agencies and with
the high intensity drug trafficking area;
``(F) the nature and extent to which information sharing
and enforcement activities are coordinated with joint terrorism
task forces in the high intensity drug trafficking area; and
``(G) any recommendations for measures needed to ensure
that task force resources are utilized efficiently and
effectively to reduce the availability of illegal drugs in the
high intensity drug trafficking areas.
``(m) Assessment of Law Enforcement Intelligence Sharing in High
Intensity Drug Trafficking Areas Program.--Not later than 180 days
after the date of the enactment of this section, and as part of each
subsequent annual National Drug Control Strategy report, the Director,
in consultation with the Director of National Intelligence, shall
submit to Congress a report--
``(1) evaluating existing and planned law enforcement
intelligence systems supported by each high intensity drug
trafficking area, or utilized by task forces receiving any funding
under the Program, including the extent to which such systems
ensure access and availability of law enforcement intelligence to
Federal, State, local, and tribal law enforcement agencies within
the high intensity drug trafficking area and outside of it;
``(2) the extent to which Federal, State, local, and tribal law
enforcement agencies participating in each high intensity drug
trafficking area are sharing law enforcement intelligence
information to assess current drug trafficking threats and design
appropriate enforcement strategies; and
``(3) the measures needed to improve effective sharing of
information and law enforcement intelligence regarding drug
trafficking and drug production among Federal, State, local, and
tribal law enforcement participating in a high intensity drug
trafficking area, and between such agencies and similar agencies
outside the high intensity drug trafficking area.
``(n) Coordination of Law Enforcement Intelligence Sharing With
Organized Crime Drug Enforcement Task Force Program.--The Director, in
consultation with the Attorney General, shall ensure that any drug
enforcement intelligence obtained by the Intelligence Support Center
for each high intensity drug trafficking area is shared, on a timely
basis, with the drug intelligence fusion center operated by the
Organized Crime Drug Enforcement Task Force of the Department of
Justice.
``(o) Use of Funds To Combat Methamphetamine Trafficking.--
``(1) Requirement.--As part of the documentation that supports
the President's annual budget request for the Office, the Director
shall submit to Congress a report describing the use of HIDTA funds
to investigate and prosecute organizations and individuals
trafficking in methamphetamine in the prior calendar year.
``(2) Contents.--The report shall include--
``(A) the number of methamphetamine manufacturing
facilities discovered through HIDTA-funded initiatives in the
previous fiscal year;
``(B) the amounts of methamphetamine or listed chemicals
(as that term is defined in section 102(33) of the Controlled
Substances Act (21 U.S.C. 802(33)) seized by HIDTA-funded
initiatives in the area during the previous year; and
``(C) law enforcement intelligence and predictive data from
the Drug Enforcement Administration showing patterns and trends
in abuse, trafficking, and transportation in methamphetamine
and listed chemicals.
``(3) Certification.--Before the Director awards any funds to a
high intensity drug trafficking area, the Director shall certify
that the law enforcement entities participating in that HIDTA are
providing laboratory seizure data to the national clandestine
laboratory database at the El Paso Intelligence Center.
``(p) Authorization of Appropriations.--There is authorized to be
appropriated to the Office of National Drug Control Policy to carry out
this section--
``(1) $240,000,000 for fiscal year 2007;
``(2) $250,000,000 for fiscal year 2008;
``(3) $260,000,000 for fiscal year 2009;
``(4) $270,000,000 for fiscal year 2010; and
``(5) $280,000,000 for each of fiscal year 2011.''.
SEC. 302. FUNDING FOR CERTAIN HIGH INTENSITY DRUG TRAFFICKING
AREAS.
(a) Short Title.--This section may be cited as the ``Dawson Family
Community Protection Act''.
(b) Findings.--Congress finds the following:
(1) In the early morning hours of October 16, 2002, the home of
Carnell and Angela Dawson was firebombed in apparent retaliation
for Mrs. Dawson's notification to police about persistent drug
distribution activity in their East Baltimore City neighborhood.
(2) The arson claimed the lives of Mr. and Mrs. Dawson and
their 5 young children, aged 9 to 14.
(3) The horrific murder of the Dawson family is a stark example
of domestic narco-terrorism.
(4) In all phases of counternarcotics law enforcement--from
prevention to investigation to prosecution to reentry--the
voluntary cooperation of ordinary citizens is a critical component.
(5) Voluntary cooperation is difficult for law enforcement
officials to obtain when citizens feel that cooperation carries the
risk of violent retaliation by illegal drug trafficking
organizations and their affiliates.
(6) Public confidence that law enforcement is doing all it can
to make communities safe is a prerequisite for voluntary
cooperation among people who may be subject to intimidation or
reprisal (or both).
(7) Witness protection programs are insufficient on their own
to provide security because many individuals and families who
strive every day to make distressed neighborhoods livable for their
children, other relatives, and neighbors will resist or refuse
offers of relocation by local, State, and Federal prosecutorial
agencies and because, moreover, the continued presence of strong
individuals and families is critical to preserving and
strengthening the social fabric in such communities.
(8) Where (as in certain sections of Baltimore City) interstate
trafficking of illegal drugs has severe ancillary local
consequences within areas designated as high intensity drug
trafficking areas, it is important that supplementary High
Intensity Drug Trafficking Areas Program funds be committed to
support initiatives aimed at making the affected communities safe
for the residents of those communities and encouraging their
cooperation with tribal, local, State, and Federal law enforcement
efforts to combat illegal drug trafficking.
(c) Funding for Certain High Intensity Drug Trafficking Areas.--
Section 707, as amended by section 301, is amended by adding at the end
the following:
``(q) Specific Purposes.--
``(1) In general.--The Director shall ensure that, of the
amounts appropriated for a fiscal year for the Program, at least
$7,000,000 is used in high intensity drug trafficking areas with
severe neighborhood safety and illegal drug distribution problems.
``(2) Required uses.--The funds used under paragraph (1) shall
be used--
``(A) to ensure the safety of neighborhoods and the
protection of communities, including the prevention of the
intimidation of potential witnesses of illegal drug
distribution and related activities; and
``(B) to combat illegal drug trafficking through such
methods as the Director considers appropriate, such as
establishing or operating (or both) a toll-free telephone
hotline for use by the public to provide information about
illegal drug-related activities.''.
SEC. 303. ASSESSMENT.
The Director shall assess the ability of the HIDTA Program to
respond to the so-called ``balloon effect'', whereby urban drug
traffickers facing intensive law enforcement efforts expand and spread
their trafficking and distribution into rural, suburban, and smaller
urban areas by conducting a demonstration project examining the ability
of the New York/New Jersey HIDTA, with its new single colocated
Organized Crime and Drug Enforcement Task Force/High Intensity Drug
Trafficking Area Strike Force and HIDTA Regional Intelligence Center,
to address the movement of drug traffickers into the more rural,
suburban, and smaller areas encompassed by the counties of Albany,
Onondaga, Monroe, and Erie in New York State and by annexing these
counties into the existing New York/New Jersey HIDTA.
TITLE IV--TECHNOLOGY
SEC. 401. COUNTERDRUG TECHNOLOGY ASSESSMENT CENTER.
(a) Chief Scientist.--Section 708(b) is amended to read as follows:
``(b) Chief Scientist.--There shall be at the head of the Center
the Chief Scientist, who shall be appointed by the Director from among
individuals qualified and distinguished in the area of science,
medicine, engineering, or technology.''.
(b) Responsibilities.--
(1) Research and development.--Section 708 is amended by--
(A) redesignating subsection (d) as subsection (e); and
(B) striking subsection (c) and inserting the following:
``(c) Research and Development Responsibilities.--The Director,
acting through the Chief Scientist, shall--
``(1) identify and define the short-, medium-, and long-term
scientific and technological needs of Federal, State, local, and
tribal drug supply reduction agencies, including--
``(A) advanced surveillance, tracking, and radar imaging;
``(B) electronic support measures;
``(C) communications;
``(D) data fusion, advanced computer systems, and
artificial intelligence; and
``(E) chemical, biological, radiological (including neutron
and electron), and other means of detection;
``(2) identify demand reduction basic and applied research
needs and initiatives, in consultation with affected National Drug
Control Program agencies, including--
``(A) improving treatment through neuroscientific advances;
``(B) improving the transfer of biomedical research to the
clinical setting; and
``(C) in consultation with the National Institute of Drug
Abuse and the Substance Abuse and Mental Health Services
Administration, and through interagency agreements or grants,
examining addiction and rehabilitation research and the
application of technology to expanding the effectiveness and
availability of drug treatment;
``(3) make a priority ranking of such needs identified in
paragraphs (1) and (2) according to fiscal and technological
feasibility, as part of a National Counterdrug Research and
Development Program;
``(4) oversee and coordinate counterdrug technology initiatives
with related activities of other Federal civilian and military
departments;
``(5) provide support to the development and implementation of
the national drug control performance measurement system
established under subsection (c) of section 706; and
``(6) pursuant to the authority of the Director of National
Drug Control Policy under section 704, submit requests to Congress
for the reprogramming or transfer of funds appropriated for
counterdrug technology research and development.
``(d) Limitation on Authority.--The authority granted to the
Director under this section shall not extend to the awarding of
contracts, management of individual projects, or other operational
activities.''.
(2) Assistance and support.--Subsection (e) of section 708, as
redesignated by this section, is amended to read as follows:
``(e) Assistance and Support to the Office of National Drug Control
Policy.--The Secretary of Defense, the Secretary of Homeland Security,
and the Secretary of Health and Human Services shall, to the maximum
extent practicable, render assistance and support to the Office and to
the Director in the conduct of counterdrug technology assessment.''.
(3) Technology transfer program.--Section 708 is amended by
adding at the end the following:
``(f) Technology Transfer Program.--
``(1) Program.--The Chief Scientist, with the advice and
counsel of experts from State, local, and tribal law enforcement
agencies, shall be responsible to the Director for coordination and
implementation of a counterdrug technology transfer program.
``(2) Purpose.--The purpose of the Technology Transfer Program
shall be for the Counterdrug Technology Assessment Center to
transfer technology and associated training directly to State,
local, and tribal law enforcement agencies.
``(3) Priority of receipts.--Transfers shall be made in
priority order based on--
``(A) the need of potential recipients for such technology;
``(B) the effectiveness of the technology to enhance
current counterdrug activities of potential recipients; and
``(C) the ability and willingness of potential recipients
to evaluate transferred technology.
``(4) Agreement authority.--The Director may enter into an
agreement with the Secretary of Homeland Security to transfer
technology with both counterdrug and homeland security applications
to State, local, and tribal law enforcement agencies on a
reimbursable basis.
``(5) Report.--On or before July 1 of each year, the Director
shall submit a report to the appropriate congressional committees
that addresses the following:
``(A) The number of requests received during the previous
12 months, including the identity of each requesting agency and
the type of technology requested.
``(B) The number of requests fulfilled during the previous
12 months, including the identity of each recipient agency and
the type of technology transferred.
``(C) A summary of the criteria used in making the
determination on what requests were funded and what requests
were not funded, except that such summary shall not include
specific information on any individual requests.
``(D) A general assessment of the future needs of the
program, based on expected changes in threats, expected
technologies, and likely need from potential recipients.
``(E) An assessment of the effectiveness of the
technologies transferred, based in part on the evaluations
provided by the recipients, with a recommendation whether the
technology should continue to be offered through the
program.''.
(c) Assistance From Secretary of Homeland Security.--Section 708(d)
(21 U.S.C. 1707(d)) is amended by inserting ``, the Secretary of
Homeland Security,'' after ``The Secretary of Defense''.
TITLE V--NATIONAL YOUTH MEDIA CAMPAIGN
SEC. 501. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN.
(a) In General.--Section 709 (21 U.S.C. 1708) is amended to read as
follows:
``SEC. 709. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN.
``(a) In General.--The Director shall conduct a national youth
anti-drug media campaign (referred to in this subtitle as the `national
media campaign') in accordance with this section for the purposes of--
``(1) preventing drug abuse among young people in the United
States;
``(2) increasing awareness of adults of the impact of drug
abuse on young people; and
``(3) encouraging parents and other interested adults to
discuss with young people the dangers of illegal drug use.
``(b) Use of Funds.--
``(1) In general.--Amounts made available to carry out this
section for the national media campaign may only be used for the
following:
``(A) The purchase of media time and space, including the
strategic planning for, and accounting of, such purchases.
``(B) Creative and talent costs, consistent with paragraph
(2)(A).
``(C) Advertising production costs.
``(D) Testing and evaluation of advertising.
``(E) Evaluation of the effectiveness of the national media
campaign.
``(F) The negotiated fees for the winning bidder on
requests for proposals issued either by the Office or its
designee to enter into contracts to carry out activities
authorized by this section.
``(G) Partnerships with professional and civic groups,
community-based organizations, including faith-based
organizations, and government organizations related to the
national media campaign.
``(H) Entertainment industry outreach, interactive
outreach, media projects and activities, public information,
news media outreach, and corporate sponsorship and
participation.
``(I) Operational and management expenses.
``(2) Specific requirements.--
``(A) Creative services.--
``(i) In using amounts for creative and talent costs
under paragraph (1)(B), the Director shall use creative
services donated at no cost to the Government (including
creative services provided by the Partnership for a Drug-
Free America) wherever feasible and may only procure
creative services for advertising--
``(I) responding to high-priority or emergent
campaign needs that cannot timely be obtained at no
cost; or
``(II) intended to reach a minority, ethnic, or
other special audience that cannot reasonably be
obtained at no cost; or
``(III) the Director determines that the
Partnership for a Drug-Free America is unable to
provide, pursuant to subsection (d)(2)(B).
``(ii) Subject to the availability of appropriations,
no more than $1,500,000 may be expended under this section
each fiscal year on creative services, except that the
Director may expend up to $2,000,000 in a fiscal year on
creative services to meet urgent needs of the national
media campaign with advance approval from the Committee on
Appropriations of the Senate and of the House of
Representatives upon a showing of the circumstances causing
such urgent needs of the national media campaign.
``(B) Testing and evaluation of advertising.--In using
amounts for testing and evaluation of advertising under
paragraph (1)(D), the Director shall test all advertisements
prior to use in the national media campaign to ensure that the
advertisements are effective and meet industry-accepted
standards. The Director may waive this requirement for
advertisements using no more than 10 percent of the purchase of
advertising time purchased under this section in a fiscal year
and no more than 10 percent of the advertising space purchased
under this section in a fiscal year, if the advertisements
respond to emergent and time-sensitive campaign needs or the
advertisements will not be widely utilized in the national
media campaign.
``(C) Evaluation of effectiveness of media campaign.--In
using amounts for the evaluation of the effectiveness of the
national media campaign under paragraph (1)(E), the Director
shall--
``(i) designate an independent entity to evaluate by
April 20 of each year the effectiveness of the national
media campaign based on data from--
``(I) the Monitoring the Future Study published by
the Department of Health and Human Services;
``(II) the Attitude Tracking Study published by the
Partnership for a Drug-Free America;
``(III) the National Household Survey on Drug
Abuse; and
``(IV) other relevant studies or publications, as
determined by the Director, including tracking and
evaluation data collected according to marketing and
advertising industry standards; and
``(ii) ensure that the effectiveness of the national
media campaign is evaluated in a manner that enables
consideration of whether the national media campaign has
contributed to reduction of illicit drug use among youth
and such other measures of evaluation as the Director
determines are appropriate.
``(3) Purchase of advertising time and space.--Subject to the
availability of appropriations, for each fiscal year, not less than
77 percent of the amounts appropriated under this section shall be
used for the purchase of advertising time and space for the
national media campaign, subject to the following exceptions:
``(A) In any fiscal year for which less than $125,000,000
is appropriated for the national media campaign, not less than
72 percent of the amounts appropriated under this section shall
be used for the purchase of advertising time and space for the
national media campaign.
``(B) In any fiscal year for which more than $195,000,000
is appropriated under this section, not less than 82 percent
shall be used for advertising production costs and the purchase
of advertising time and space for the national media campaign.
``(c) Advertising.--In carrying out this section, the Director
shall ensure that sufficient funds are allocated to meet the stated
goals of the national media campaign.
``(d) Division of Responsibilities and Functions Under the
Program.--
``(1) In general.--The Director, in consultation with the
Partnership for a Drug-Free America, shall determine the overall
purposes and strategy of the national media campaign.
``(2) Responsibilities.--
``(A) Director.--The Director shall be responsible for
implementing a focused national media campaign to meet the
purposes set forth in subsection (a), and shall approve--
``(i) the strategy of the national media campaign;
``(ii) all advertising and promotional material used in
the national media campaign; and
``(iii) the plan for the purchase of advertising time
and space for the national media campaign.
``(B) The partnership for a drug-free america.--The
Director shall request that the Partnership for a Drug-Free
America--
``(i) develop and recommend strategies to achieve the
goals of the national media campaign, including addressing
national and local drug threats in specific regions or
States, such as methamphetamine and ecstasy;
``(ii) create all advertising to be used in the
national media campaign, except advertisements that are--
``(I) provided by other nonprofit entities pursuant
to subsection (f);
``(II) intended to respond to high-priority or
emergent campaign needs that cannot timely be obtained
at no cost (not including production costs and talent
reuse payments), provided that any such advertising
material is reviewed by the Partnership for a Drug-Free
America;
``(III) intended to reach a minority, ethnic, or
other special audience that cannot be obtained at no
cost (not including production costs and talent reuse
payments), provided that any such advertising material
is reviewed by the Partnership for a Drug-Free America;
or
``(IV) any other advertisements that the Director
determines that the Partnership for a Drug-Free America
is unable to provide or if the Director determines that
another entity is more appropriate, subject to the
requirements of subsection (b)(2)(A).
If the Director determines that another entity is more
appropriate under clause (ii)(IV), the Director shall notify
Congress, through the committees of jurisdiction in the House
and Senate, in writing, not less than 30 days prior to
contracting with a party other than the Partnership for a Drug-
Free America.
``(C) Media buying contractor.--The Director shall enter
into a contract with a media buying contractor to plan and
purchase advertising time and space for the national media
campaign. The media buying contractor shall not provide any
other service or material, or conduct any other function or
activity which the Director determines should be provided by
the Partnership for a Drug-Free America.
``(e) Prohibitions.--None of the amounts made available under
subsection (b) may be obligated or expended for any of the following:
``(1) To supplant current anti-drug community-based coalitions.
``(2) To supplant pro bono public service time donated by
national and local broadcasting networks for other public service
campaigns.
``(3) For partisan political purposes, or express advocacy in
support of or to defeat any clearly identified candidate, clearly
identified ballot initiative, or clearly identified legislative or
regulatory proposal.
``(4) To fund advertising that features any elected officials,
persons seeking elected office, cabinet level officials, or other
Federal officials employed pursuant to section 213 of Schedule C of
title 5, Code of Federal Regulations.
``(5) To fund advertising that does not contain a primary
message intended to reduce or prevent illicit drug use.
``(6) To fund advertising containing a primary message intended
to promote support for the media campaign or private sector
contributions to the media campaign.
``(f) Matching Requirement.--
``(1) In general.--Amounts made available under subsection (b)
for media time and space shall be matched by an equal amount of
non-Federal funds for the national media campaign, or be matched
with in-kind contributions of the same value.
``(2) No-cost match advertising direct relationship
requirement.--The Director shall ensure that at least 70 percent of
no-cost match advertising provided directly relates to substance
abuse prevention consistent with the specific purposes of the
national media campaign, except that in any fiscal year in which
less than $125,000,000 is appropriated to the national media
campaign, the Director shall ensure that at least 85 percent of no-
cost match advertising directly relates to substance abuse
prevention consistent with the specific purposes of the national
media campaign.
``(3) No-cost match advertising not directly related.--The
Director shall ensure that no-cost match advertising that does not
directly relate to substance abuse prevention consistent with the
purposes of the national media campaign includes a clear anti-drug
message. Such message is not required to be the primary message of
the match advertising.
``(g) Financial and Performance Accountability.--The Director shall
cause to be performed--
``(1) audits and reviews of costs of the national media
campaign pursuant to section 304C of the Federal Property and
Administrative Services Act of 1949 (41 U.S.C. 254d); and
``(2) an audit to determine whether the costs of the national
media campaign are allowable under section 306 of such Act (41
U.S.C. 256).
``(h) Report to Congress.--The Director shall submit on an annual
basis a report to Congress that describes--
``(1) the strategy of the national media campaign and whether
specific objectives of the media campaign were accomplished;
``(2) steps taken to ensure that the national media campaign
operates in an effective and efficient manner consistent with the
overall strategy and focus of the national media campaign;
``(3) plans to purchase advertising time and space;
``(4) policies and practices implemented to ensure that Federal
funds are used responsibly to purchase advertising time and space
and eliminate the potential for waste, fraud, and abuse; and
``(5) all contracts entered into with a corporation,
partnership, or individual working on behalf of the national media
campaign.
``(i) Local Target Requirement.--The Director shall, to the maximum
extent feasible, use amounts made available under this section for
media that focuses on, or includes specific information on, prevention
or treatment resources for consumers within specific local areas.
``(j) Prevention of Marijuana Use.--
``(1) Findings.--The Congress finds the following:
``(A) 60 percent of adolescent admissions for drug
treatment are based on marijuana use.
``(B) Potency levels of contemporary marijuana,
particularly hydroponically grown marijuana, are significantly
higher than in the past, rising from under 1 percent of THC in
the mid-1970s to as high as 30 percent today.
``(C) Contemporary research has demonstrated that youths
smoking marijuana early in life may be up to 5 times more
likely to use hard drugs.
``(D) Contemporary research has demonstrated clear
detrimental effects in adolescent educational achievement
resulting from marijuana use.
``(E) Contemporary research has demonstrated clear
detrimental effects in adolescent brain development resulting
from marijuana use.
``(F) An estimated 9,000,000 Americans a year drive while
under the influence of illegal drugs, including marijuana.
``(G) Marijuana smoke contains 50 to 70 percent more of
certain cancer causing chemicals than tobacco smoke.
``(H) Teens who use marijuana are up to 4 times more likely
to have a teen pregnancy than teens who have not.
``(I) Federal law enforcement agencies have identified
clear links suggesting that trade in hydroponic marijuana
facilitates trade by criminal organizations in hard drugs,
including heroin.
``(J) Federal law enforcement agencies have identified
possible links between trade in cannabis products and financing
for terrorist organizations.
``(2) Emphasis on prevention of youth marijuana use.--In
conducting advertising and activities otherwise authorized under
this section, the Director may emphasize prevention of youth
marijuana use.
``(k) Prevention of Methamphetamine Abuse and Other Emerging Drug
Abuse Threats.--
``(1) Requirement to use 10 percent of funds for
methamphetamine abuse prevention.--The Director shall ensure that,
of the amounts appropriated under this section for the national
media campaign for a fiscal year, not less than 10 percent shall be
expended solely for the activities described in subsection (b)(1)
with respect to advertisements specifically intended to reduce the
use of methamphetamine.
``(2) Authority to use funds for other drug abuse upon
certification that methamphetamine abuse fell during fiscal year
2007.--With respect to fiscal year 2008 and any fiscal year
thereafter, if the Director certifies in writing to Congress that
domestic methamphetamine laboratory seizures (as reported to the El
Paso Intelligence Center of the Drug Enforcement Administration)
decreased to at least 75 percent of the 2006 level, or the Director
has documented a highly, statistically significant increase in a
specific drug, from a baseline determined by locally collected
data, that can be defined as a local drug crisis, the Director may
apply paragraph (1)(A) for that fiscal year with respect to
advertisements specifically intended to reduce the use of such
other drugs.
``(l) Authorization of Appropriations.--There is authorized to be
appropriated to the Office to carry out this section, $195,000,000 for
each of fiscal years 2007 and 2008 and $210,000,000 for each of fiscal
years 2009 through 2011.''.
(b) Repeal of Superseded Provisions.--The Drug-Free Media Campaign
Act of 1998 (21 U.S.C. 1801 et seq.) is repealed.
TITLE VI--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE
SEC. 601. AUTHORIZATION OF APPROPRIATIONS.
Section 714 is amended--
(1) by striking ``title,'' and inserting ``title except
activities otherwise specified,''; and
(2) by striking ``1999 through 2003'' and inserting ``2006
through 2010''.
SEC. 602. EXTENSION OF TERMINATION DATE.
Section 715(a) is amended by striking ``September 30, 2003, this
title and the amendments made by this title'' and inserting ``September
30, 2010, this title and the amendments made to this title''.
TITLE VII--ANTI-DOPING AGENCY
SEC. 701. DESIGNATION OF UNITED STATES ANTI-DOPING AGENCY.
(a) Definitions.--In this title:
(1) United states olympic committee.--The term ``United States
Olympic Committee'' means the organization established by the ``Ted
Stevens Olympic and Amateur Sports Act'' (36 U.S.C. 220501 et
seq.).
(2) Amateur athletic competition.--The term ``amateur athletic
competition'' means a contest, game, meet, match, tournament,
regatta, or other event in which amateur athletes compete (36
U.S.C. 220501(b)(2)).
(3) Amateur athlete.--The term ``amateur athlete'' means an
athlete who meets the eligibility standards established by the
national governing body or paralympic sports organization for the
sport in which the athlete competes (36 U.S.C. 22501(b)(1)).
(4) Gene doping.--The term ``gene doping'' means the
nontherapeutic use of cells, genes, genetic elements, or of the
modulation of gene expression, having the capacity to enhance
athletic performance.
(b) In General.--The United States Anti-Doping Agency shall--
(1) serve as the independent anti-doping organization for the
amateur athletic competitions recognized by the United States
Olympic Committee;
(2) ensure that athletes participating in amateur athletic
activities recognized by the United States Olympic Committee are
prevented from using performance-enhancing drugs, or performance-
enhancing genetic modifications accomplished through gene-doping;
(3) implement anti-doping education, research, testing, and
adjudication programs to prevent United States Amateur Athletes
participating in any activity recognized by the United States
Olympic Committee from using performance-enhancing drugs, or
performance-enhancing genetic modifications accomplished through
gene-doping;
(4) serve as the United States representative responsible for
coordination with other anti-doping organizations coordinating
amateur athletic competitions recognized by the United States
Olympic Committee to ensure the integrity of athletic competition,
the health of the athletes and the prevention of use of
performance-enhancing drugs, or performance-enhancing genetic
modifications accomplished through gene-doping by United States
amateur athletes; and
(5) permanently include ``gene doping'' among any list of
prohibited substances adopted by the Agency.
SEC. 702. RECORDS, AUDIT, AND REPORT.
(a) Records.--The United States Anti-Doping Agency shall keep
correct and complete records of account.
(b) Report.--The United States Anti-Doping Agency shall submit an
annual report to Congress which shall include--
(1) an audit conducted and submitted in accordance with section
10101 of title 36, United States Code; and
(2) a description of the activities of the agency.
SEC. 703. AUTHORIZATION OF APPROPRIATIONS.
There are authorized to be appropriated to the United States Anti-
Doping Agency--
(1) for fiscal year 2007, $9,700,000;
(2) for fiscal year 2008, $10,300,000;
(3) for fiscal year 2009, $10,600,000;
(4) for fiscal year 2010, $11,000,000; and
(5) for fiscal year 2011, $11,500,000.
TITLE VIII--DRUG-FREE COMMUNITIES
SEC. 801. REAUTHORIZATION.
(a) In General.--Section 1024(a) of the Drug-Free Communities Act
of 1997 (21 U.S.C. 1524(a)) is amended--
(1) in paragraph (9), by striking ``and'' after the semicolon;
(2) in paragraph (10), by striking the period and inserting a
semicolon; and
(3) by adding at the end the following:
``(11) $109,000,000 for fiscal year 2008;
``(12) $114,000,000 for fiscal year 2009;
``(13) $119,000,000 for fiscal year 2010;
``(14) $124,000,000 for fiscal year 2011; and
``(15) $129,000,000 for fiscal year 2012.''.
(b) Administration Costs.--Section 1024(b) of the Drug-Free
Communities Act of 1997 (21 U.S.C. 1524(b)) is amended to read as
follows:
``(b) Administrative Costs.--
``(1) Limitation.--Not more than 3 percent of the funds
appropriated for this chapter may be used by the Office of National
Drug Control Policy to pay for administrative costs associated with
their responsibilities under the chapter.
``(2) Designated agency.--The agency delegated to carry out
this program under section 1031(d) may use up to 5 percent of the
funds allocated for grants under this chapter for administrative
costs associated with carrying out the program.''.
SEC. 802. SUSPENSION OF GRANTS.
(a) In General.--Section 1032(b) of the Drug-Free Communities Act
of 1997 (21 U.S.C. 1532(b)) is amended by adding at the end the
following:
``(4) Process for suspension.--A grantee shall not be suspended
or terminated under paragraph (1)(A)(ii), (2)(A)(iii), or (3)(E)
unless that grantee is afforded a fair, timely, and independent
appeal prior to such suspension or termination.''.
(b) Report to Congress.--Not later than 60 days after the date of
enactment of this Act, the Director of the Office of National Drug
Control Policy shall submit to Congress a report detailing the appeals
process required by section 1032(b)(4) of the Drug-Free Communities Act
of 1997, as added by subsection (a).
SEC. 803. GRANT AWARD INCREASE.
Subsections (b)(1)(A)(iv), (b)(2)(C)(i), and (b)(3)(F) of section
1032 of the Drug-Free Communities Act of 1997 (21 U.S.C. 1532) are
amended by striking ``$100,000'' and inserting ``$125,000''.
SEC. 804. PROHIBITION ON ADDITIONAL ELIGIBILITY CRITERIA.
Section 1032(a) of the Drug-Free Communities Act of 1997 (21 U.S.C.
1532(a)) is amended by adding at the end the following:
``(7) Additional criteria.--The Director shall not impose any
eligibility criteria on new applicants or renewal grantees not
provided in this chapter.''.
SEC. 805. NATIONAL COMMUNITY ANTI-DRUG COALITION INSTITUTE.
Section 4 of Public Law 107-82 (21 U.S.C. 1521 note), reauthorizing
the Drug-Free Communities Support Program, is amended--
(1) by amending subsection (a) to read as follows:
``(a) In General.--The Director of the Office of National Drug
Control Policy shall, using amounts authorized to be appropriated by
subsection (d), make a directed grant to Community Anti-Drug Coalitions
of America to provide for the continuation of the National Community
Anti-drug Coalition Institute.'';
(2) by striking subsection (b) and redesignating subsections
(c) and (d) as (b) and (c), respectively; and
(3) in subsection (c), as redesignated by paragraph (2), by
adding at the end the following:
``(4) For each of the fiscal years 2008 through 2012,
$2,000,000.''.
TITLE IX--NATIONAL GUARD COUNTERDRUG SCHOOLS
SEC. 901. NATIONAL GUARD COUNTERDRUG SCHOOLS.
(a) Authority To Operate.--Under such regulations as the Secretary
of Defense may prescribe, the Chief of the National Guard Bureau may
establish and operate, or provide financial assistance to the States to
establish and operate, not more than 5 schools (to be known generally
as ``National Guard counterdrug schools'').
(b) Purpose.--The purpose of the National Guard counterdrug schools
shall be the provision by the National Guard of training in drug
interdiction and counterdrug activities and drug demand reduction
activities to personnel of the following:
(1) Federal agencies.
(2) State, local, and tribal law enforcement agencies.
(3) Community-based organizations engaged in such activities.
(4) Other non-Federal governmental and private entities and
organizations engaged in such activities.
(c) Counterdrug Schools Specified.--The National Guard counterdrug
schools operated under the authority in subsection (a) are as follows:
(1) The National Interagency Civil-Military Institute (NICI),
San Luis Obispo, California.
(2) The Multi-Jurisdictional Counterdrug Task Force Training
(MCTFT), St. Petersburg, Florida.
(3) The Midwest Counterdrug Training Center (MCTC), Johnston,
Iowa.
(4) The Regional Counterdrug Training Academy (RCTA), Meridian,
Mississippi.
(5) The Northeast Regional Counterdrug Training Center (NCTC),
Fort Indiantown Gap, Pennsylvania.
(d) Use of National Guard Personnel.--
(1) In general.--To the extent provided for in the State drug
interdiction and counterdrug activities plan of a State in which a
National Guard counterdrug school is located, personnel of the
National Guard of that State who are ordered to perform full-time
National Guard duty authorized under section 112(b) of that title
32, United States Code, may provide training referred to in
subsection (b) at that school.
(2) Definition.--In this subsection, the term ``State drug
interdiction and counterdrug activities plan'', in the case of a
State, means the current plan submitted by the Governor of the
State to the Secretary of Defense under section 112 of title 32,
United States Code.
(e) Treatment Under Authority To Provide Counterdrug Support.--The
provisions of section 1004 of the National Defense Authorization Act
for Fiscal Year 1991 (Public Law 101-510; 10 U.S.C. 374 note) shall
apply to any activities of a National Guard counterdrug school under
this section that are for an agency referred to in subsection (a) of
such section 1004 and for a purpose set forth in subsection (b) of such
section 1004.
(f) Annual Reports on Activities.--
(1) In general.--Not later than February 1 each year, the
Secretary of Defense shall submit to Congress a report on the
activities of the National Guard counterdrug schools during the
preceding year.
(2) Contents.--Each report under paragraph (1) shall set forth
the following:
(A) Funding.--The amount made available for each National
Guard counterdrug school during the fiscal year ending in the
year preceding the year in which such report is submitted.
(B) Activities.--A description of the activities of each
National Guard counterdrug school during the year preceding the
year in which such report is submitted.
(g) Authorization of Appropriations.--
(1) In general.--There is hereby authorized to be appropriated
for the Department of Defense for the National Guard for each of
fiscal years 2006 through 2010, $30,000,000 for purposes of the
National Guard counterdrug schools in such fiscal year.
(2) Construction.--The amount authorized to be appropriated by
paragraph (1) for a fiscal year is in addition to any other amount
authorized to be appropriated for the Department of Defense for the
National Guard for such fiscal year.
TITLE X--NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE ACT OF 2006
SEC. 1001. SHORT TITLE.
This title may be cited as the ``National Methamphetamine
Information Clearinghouse Act of 2006''.
SEC. 1002. DEFINITIONS.
In this title--
(1) the term ``Council'' means the National Methamphetamine
Advisory Council established under section 1003(b)(1);
(2) the term ``drug endangered children'' means children whose
physical, mental, or emotional health are at risk because of the
production, use, or other effects of methamphetamine production or
use by another person;
(3) the term ``National Methamphetamine Information
Clearinghouse'' or ``NMIC'' means the information clearinghouse
established under section 1003(a); and
(4) the term ``qualified entity'' means a State, local, or
tribal government, school board, or public health, law enforcement,
nonprofit, community anti-drug coalition, or other nongovernmental
organization providing services related to methamphetamines.
SEC. 1003. ESTABLISHMENT OF CLEARINGHOUSE AND ADVISORY COUNCIL.
(a) Clearinghouse.--There is established, under the supervision of
the Attorney General of the United States, an information clearinghouse
to be known as the National Methamphetamine Information Clearinghouse.
(b) Advisory Council.--
(1) In general.--There is established an advisory council to be
known as the National Methamphetamine Advisory Council.
(2) Membership.--The Council shall consist of 10 members
appointed by the Attorney General--
(A) not fewer than 3 of whom shall be representatives of
law enforcement agencies;
(B) not fewer than 4 of whom shall be representatives of
nongovernmental and nonprofit organizations providing services
or training and implementing programs or strategies related to
methamphetamines; and
(C) 1 of whom shall be a representative of the Department
of Health and Human Services.
(3) Period of appointment; vacancies.--Members shall be
appointed for 3 years. Any vacancy in the Council shall not affect
its powers, but shall be filled in the same manner as the original
appointment.
(4) Personnel matters.--
(A) Travel expenses.--The members of the Council shall be
allowed travel expenses, including per diem in lieu of
subsistence, at rates authorized for employees of agencies
under subchapter I of chapter 57 of title 5, United States
Code, while away from their homes or regular places of business
in the performance of services for the Council.
(B) No compensation.--The members of the Council shall not
receive compensation for the performance of the duties of a
member of the Council.
SEC. 1004. NMIC REQUIREMENTS AND REVIEW.
(a) In General.--The NMIC shall promote sharing information
regarding successful law enforcement, treatment, environmental,
prevention, social services, and other programs related to the
production, use, or effects of methamphetamine and grants available for
such programs.
(b) Components.--The NMIC shall include--
(1) a toll-free number; and
(2) a website that provides a searchable database, which--
(A) provides information on the short-term and long-term
effects of methamphetamine use;
(B) provides information regarding methamphetamine
treatment and prevention programs and strategies and programs
for drug endangered children, including descriptions of
successful programs and strategies and contact information for
such programs and strategies;
(C) provides information regarding grants for
methamphetamine-related programs, including contact information
and links to websites;
(D) allows a qualified entity to submit items to be posted
on the website regarding successful public or private programs
or other useful information related to the production, use, or
effects of methamphetamine;
(E) includes a restricted section that may only be accessed
by a law enforcement organization that contains successful
strategies, training techniques, and other information that the
Council determines helpful to law enforcement agency efforts to
identify or combat the production, use, or effects of
methamphetamine;
(F) allows public access to all information not in a
restricted section; and
(G) contains any additional information the Council
determines may be useful in identifying or combating the
production, use, or effects of methamphetamine.
Thirty days after the website in paragraph (2) is operational, no funds
shall be expended to continue the website methresources.gov.
(c) Review of Posted Information.--
(1) In general.--Not later than 30 days after the date of
submission of an item by a qualified entity, the Council shall
review an item submitted for posting on the website described in
subsection (b)(2)--
(A) to evaluate and determine whether the item, as
submitted or as modified, meets the requirements for posting;
and
(B) in consultation with the Attorney General, to determine
whether the item should be posted in a restricted section of
the website.
(2) Determination.--Not later than 45 days after the date of
submission of an item, the Council shall--
(A) post the item on the website described in subsection
(b)(2); or
(B) notify the qualified entity that submitted the item
regarding the reason such item shall not be posted and
modifications, if any, that the qualified entity may make to
allow the item to be posted.
SEC. 1005. AUTHORIZATION OF APPROPRIATIONS.
There are authorized to be appropriated--
(1) for fiscal year 2007--
(A) $500,000 to establish the NMIC and Council; and
(B) such sums as are necessary for the operation of the
NMIC and Council; and
(2) for each of fiscal years 2008 and 2009, such sums as are
necessary for the operation of the NMIC and Council.
TITLE XI--MISCELLANEOUS PROVISIONS
SEC. 1101. REPEALS.
(a) Act.--Section 710 is repealed.
(b) Forfeiture Assets.--Section 6073 of the Assets Forfeiture
Amendments Act of 1988 (21 U.S.C. 1509) is repealed.
SEC. 1102. CONTROLLED SUBSTANCES ACT AMENDMENTS.
Section 303(g)(2) of the Controlled Substances Act (21 U.S.C.
823(g)(2)) is amended--
(1) in subparagraph (B)(iii), by striking ``except that the''
and inserting the following: ``unless, not sooner than 1 year after
the date on which the practitioner submitted the initial
notification, the practitioner submits a second notification to the
Secretary of the need and intent of the practitioner to treat up to
100 patients. A second notification under this clause shall contain
the certifications required by clauses (i) and (ii) of this
subparagraph. The''; and
(2) in subparagraph (J)--
(A) in clause (i), by striking ``thereafter'' and all that
follows through the period and inserting ``thereafter.'';
(B) in clause (ii), by striking ``Drug Addiction Treatment
Act of 2000'' and inserting ``Office of National Drug Control
Policy Reauthorization Act of 2006''; and
(C) in clause (iii), by striking ``this paragraph should
not remain in effect, this paragraph ceases to be in effect''
and inserting ``subparagraph (B)(iii) should be applied by
limiting the total number of patients a practitioner may treat
to 30, then the provisions in such subparagraph (B)(iii)
permitting more than 30 patients shall not apply, effective''.
SEC. 1103. REPORT ON LAW ENFORCEMENT INTELLIGENCE SHARING.
Not later than 180 days after the date of enactment of this Act,
the Director shall submit to Congress a report--
(1) evaluating existing and planned law enforcement
intelligence systems used by Federal, State, local, and tribal law
enforcement agencies responsible for drug trafficking and drug
production enforcement; and
(2) addressing--
(A) the current law enforcement intelligence systems used
by Federal, State, local, and tribal law enforcement agencies;
(B) the compatibility of such systems in ensuring access
and availability of law enforcement intelligence to Federal,
State, local, and tribal law enforcement;
(C) the extent to which Federal, State, local, and tribal
law enforcement are sharing law enforcement intelligence
information to assess current threats and design appropriate
enforcement strategies; and
(D) the measures needed to ensure and to promote effective
information sharing among law enforcement intelligence systems
operated by Federal, State, local, and tribal law enforcement
agencies responsible for drug trafficking and drug production
enforcement.
SEC. 1104. REQUIREMENT FOR SOUTH AMERICAN HEROIN STRATEGY.
(a) In General.--Not later than 90 days after the date of enactment
of this Act, the Director, in coordination with the Secretary of State,
shall submit to Congress a comprehensive strategy that addresses the
increased threat from South American heroin, and in particular
Colombian heroin, and the emerging threat from opium poppy grown in
Peru and often intended for transit to Columbia for processing into
heroin.
(b) Contents.--The strategy submitted under subsection (a) shall
include--
(1) opium eradication efforts to eliminate the problem at the
source to prevent heroin from entering the stream of commerce;
(2) interdiction and precursor chemical controls;
(3) demand reduction and treatment;
(4) alternative development programs, including direct
assistance to regional governments to demobilize and provide
alternative livelihoods to former members of insurgent or other
groups engaged in heroin, cocoa, or other illicit drug production
or trafficking;
(5) efforts to inform and involve local citizens in the
programs described in paragraphs (1) through (4), such as through
leaflets advertising rewards for information; and
(6) an assessment of the specific level of funding and
resources necessary to simultaneously address the threat from South
American heroin and the threat from Colombian and Peruvian coca.
(c) Treatment of Classified or Law Enforcement Sensitive
Information.--Any content of the strategy submitted under subsection
(a) that involves information classified under criteria established by
an Executive order, or whose public disclosure, as determined by the
Director or the head of any relevant Federal agency, would be
detrimental to the law enforcement of national security activities of
any Federal, foreign, or international agency, shall be presented to
Congress separately from the rest of the strategy.
SEC. 1105. MODEL ACTS.
(a) In General.--The Director of the Office of National Drug
Control Policy shall provide for or shall enter into an agreement with
a non-profit corporation that is described in section 501(c)(3) of the
Internal Revenue Code of 1986 and exempt from tax under section 501(a)
of such Code to--
(1) advise States on establishing laws and policies to address
alcohol and other drug issues, based on the model State drug laws
developed by the President's Commission on Model State Drug Laws in
1993; and
(2) revise such model State drug laws and draft supplementary
model State laws to take into consideration changes in the alcohol
and drug abuse problems in the State involved.
(b) Authorization of Appropriations.--There is authorized to be
appropriated to carry out this subsection $1,500,000 for each of fiscal
years 2007 through 2011.
SEC. 1106. STUDY ON IATROGENIC ADDICTION ASSOCIATED WITH PRESCRIPTION
OPIOID ANALGESIC DRUGS.
(a) In General.--
(1) Study.--The Director of the Office of National Drug Control
Policy shall request the Institute of Medicine of the National
Academy of Sciences to enter into an agreement under which the
Institute agrees to study certain aspects of iatrogenic addiction
to prescription opioid analgesics included in schedules II and III
of the Controlled Substances Act (21 U.S.C. 812).
(2) Iatrogenic addiction.--In this section, the term
``iatrogenic addiction'' means an addiction developed from the use
of an opioid analgesic by an individual with no previous history of
any addiction, who has lawfully obtained and used the drug for a
legitimate medical purpose by administration from, or pursuant to
the prescription or order of, an individual practitioner acting in
the usual course of professional practice.
(b) Requirements.--The study conducted pursuant to this section
shall assess the current scientific literature to determine, if
possible--
(1) the rate of iatrogenic addiction associated with the
appropriate use of prescription drugs described in subsection (a);
(2) the impact of iatrogenic addiction associated with the
appropriate use of prescription drugs described in subsection (a)
on the individual, the prescriber, other patients, and society in
general;
(3) the comparative abuse liability of prescription drugs
described in subsection (a) when used properly by the ultimate user
for a legitimate medical purpose; and
(4)(A) what types of prospective or retrospective studies
should be undertaken to determine the rate of iatrogenic addiction
associated with the appropriate use of the prescription drugs
described in subsection (a); and
(B) a feasible timeline for conducting and reporting such
studies, should the current state of the scientific literature be
insufficient to determine the rate, impact, and comparative abuse
liability of prescription drugs described in subsection (a).
(c) Report.--Not later than 1 year after the date of enactment of
this Act, the Director of the Office of National Drug Control Policy
shall ensure that the agreement under subsection (a) provides for the
submission of a report to the Congress on the status of the study
conducted pursuant to this section.
SEC. 1107. REQUIREMENT FOR STRATEGY TO STOP INTERNET ADVERTISING OF
PRESCRIPTION MEDICINES WITHOUT A PRESCRIPTION.
Not later than 120 days after the date of the enactment of this
Act, the Director of the Office of National Drug Control Policy shall
submit to Congress a strategy to stop advertisements that provide
information about obtaining over the Internet drugs (as defined in
section 702(3) of the Office of National Drug Control Policy
Reauthorization Act of 1998) for which a prescription is required
without the use of such a lawful prescription.
SEC. 1108. REQUIREMENT FOR STUDY ON DIVERSION AND INAPPROPRIATE USES OF
PRESCRIPTION DRUGS.
Not later than 90 days after the date of enactment of this Act, the
Director of the Office of National Drug Control Policy, in consultation
with the Secretary of Health and Human Services, shall submit to
Congress a report that includes a plan to conduct a study on the
illegal diversion and inappropriate uses of prescription drugs,
including the following:
(1) Methods to utilize both public use surveys that are in
existence as of the date of enactment of this Act and other surveys
to provide appropriate baseline data on the natural history of
diversion and abuse of prescription drugs that are included in
schedules under the Controlled Substances Act to evaluate the
extent and nature of potential problems with such use to guide
corrective actions which may reduce such problems without
unintentionally hindering access to these drugs for legitimate
medical purposes. Specifically, other surveys to be considered are
those that address the abuse of these substances on a regional or
national basis, and those that address the diversion of these
substances on a regional or national basis.
(2) A scientifically based analysis of the relative
contribution of both innate and acquired genetic factors,
environmental factors, psychological factors, and drug
characteristics that contribute to addiction to prescription drugs.
SEC. 1109. REQUIREMENT FOR AFGHAN HEROIN STRATEGY.
(a) In General.--Not later than 90 days after the date of the
enactment of this Act, the Director of the Office of National Drug
Control Policy shall submit to the Congress a comprehensive strategy
that addresses the increased threat from Afghan heroin.
(b) Contents.--The strategy shall include--
(1) opium crop eradication efforts to eliminate the problem at
the source to prevent heroin from entering the stream of commerce;
(2) destruction or other direct elimination of stockpiles of
heroin and raw opium, and heroin production and storage facilities;
(3) interdiction and precursor chemical controls;
(4) demand reduction and treatment;
(5) alternative development programs;
(6) measures to improve cooperation and coordination between
Federal Government agencies, and between such agencies, agencies of
foreign governments, and international organizations with
responsibility for the prevention of heroin production in, or
trafficking out of, Afghanistan; and
(7) an assessment of the specific level of funding and
resources necessary to significantly reduce the production and
trafficking of heroin.
(c) Treatment of Classified or Law Enforcement Sensitive
Information.--Any content of the strategy that involves information
classified under criteria established by an Executive order, or whose
public disclosure, as determined by the Director or the head of any
relevant Federal agency, would be detrimental to the law enforcement or
national security activities of any Federal, foreign, or international
agency, shall be presented to Congress separately from the rest of the
strategy.
SEC. 1110. REQUIREMENT FOR SOUTHWEST BORDER COUNTERNARCOTICS STRATEGY.
(a) In General.--Not later than 120 days after the date of
enactment of this Act, and every 2 years thereafter, the Director of
National Drug Control Policy shall submit to the Congress a Southwest
Border Counternarcotics Strategy.
(b) Purposes.--The Southwest Border Counternarcotics Strategy
shall--
(1) set forth the Government's strategy for preventing the
illegal trafficking of drugs across the international border
between the United States and Mexico, including through ports of
entry and between ports of entry on that border;
(2) state the specific roles and responsibilities of the
relevant National Drug Control Program agencies (as defined in
section 702 of the Office of National Drug Control Policy
Reauthorization Act of 1998 (21 U.S.C. 1701)) for implementing that
strategy; and
(3) identify the specific resources required to enable the
relevant National Drug Control Program agencies to implement that
strategy.
(c) Specific Content Related to Drug Tunnels Between the United
States and Mexico.--The Southwest Border Counternarcotics Strategy
shall include--
(1) a strategy to end the construction and use of tunnels and
subterranean passages that cross the international border between
the United States and Mexico for the purpose of illegal trafficking
of drugs across such border; and
(2) recommendations for criminal penalties for persons who
construct or use such a tunnel or subterranean passage for such a
purpose.
(d) Consultation With Other Agencies.--The Director shall issue the
Southwest Border Counternarcotics Strategy in consultation with the
heads of the relevant National Drug Control Program agencies.
(e) Limitation.--The Southwest Border Counternarcotics Strategy
shall not change existing agency authorities or the laws governing
interagency relationships, but may include recommendations about
changes to such authorities or laws.
(f) Report to Congress.--The Director shall provide a copy of the
Southwest Border Counternarcotics Strategy to the appropriate
congressional committees (as defined in section 702 of the Office of
National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C.
1701)), and to the Committee on Armed Services and the Committee on
Homeland Security of the House of Representatives, and the Committee on
Homeland Security and Governmental Affairs and the Committee on Armed
Services of the Senate.
(g) Treatment of Classified or Law Enforcement Sensitive
Information.--Any content of the Southwest Border Counternarcotics
Strategy that involves information classified under criteria
established by an Executive order, or whose public disclosure, as
determined by the Director or the head of any relevant National Drug
Control Program agency, would be detrimental to the law enforcement or
national security activities of any Federal, State, local, or tribal
agency, shall be presented to Congress separately from the rest of the
strategy.
SEC. 1111. REQUIREMENT FOR SCIENTIFIC STUDY OF MYCOHERBICIDE IN ILLICIT
DRUG CROP ERADICATION.
(a) Requirement.--Not later than 90 days after the date of
enactment of this Act, the Director of the Office of National Drug
Control Policy shall submit to the Congress a report that includes a
plan to conduct, on an expedited basis, a scientific study of the use
of mycoherbicide as a means of illicit drug crop elimination by an
appropriate Government scientific research entity, including a complete
and thorough scientific peer review. The study shall include an
evaluation of the likely human health and environmental impacts of
mycoherbicides derived from fungus naturally existing in the soil.
(b) Study.--The study required by this section shall be conducted
in United States territory and not in any foreign country.
SEC. 1112. REQUIREMENT FOR STUDY OF STATE PRECURSOR CHEMICAL CONTROL
LAWS.
(a) Study.--The Director of National Drug Control Policy, in
consultation with the National Alliance for Model State Drug Laws,
shall conduct a study of State laws with respect to precursor chemical
controls.
(b) Report.--Not later than 6 months after the date of the
enactment of this Act, the Director of National Drug Control Policy
shall submit a report to Congress on the results of the study under
subsection (a), including--
(1) a comparison of the State laws studied and the
effectiveness of each such law; and
(2) a list of best practices observed with respect to such
laws.
SEC. 1113. REQUIREMENT FOR STUDY OF DRUG ENDANGERED CHILDREN PROGRAMS.
(a) Study.--The Director of National Drug Control Policy shall
conduct a study of methamphetamine-related activities that are
conducted by different Drug Endangered Children programs administered
by States.
(b) Report.--Not later than 6 months after the date of the
enactment of this Act, the Director of National Drug Control Policy
shall submit to Congress a report on the results of the study under
subsection (a). Such report shall include--
(1) an analysis of the best practices of the activities
studied; and
(2) recommendations for establishing a national policy to
address drug endangered children, based on the Drug Endangered
Children programs administered by States.
(c) Definitions.--In this section--
(1) the term ``methamphetamine-related activity'' means any
activity related to the production, use, or effects of
methamphetamine; and
(2) the term ``drug endangered children'' means children whose
physical, mental, or emotional health are at risk because of the
production, use, or effects of methamphetamine by another person.
SEC. 1114. STUDY ON DRUG COURT HEARINGS IN NONTRADITIONAL PLACES.
(a) Finding.--Congress finds that encouraging drug courts and
schools to enter into partnerships that allow students to see the
repercussions of drug abuse by non-violent offenders may serve as a
strong deterrent and promote demand reduction.
(b) Study.--The Director of the Office of National Drug Control
Policy shall conduct a study on drug court programs that conduct
hearings in nontraditional public places, such as schools. At a
minimum, the study shall evaluate similar programs in operation, such
as the program operated in the Fourth Judicial District Drug Court, in
Washington County, Arkansas.
(c) Requirement.--At the same time the President submits to
Congress the National Drug Control Strategy due February 1, 2007,
pursuant to section 706 of the Office of National Drug Control Policy
Reauthorization Act of 1998, the President shall submit to Congress a
report on the study conducted under subsection (b). The report shall
include an evaluation of the results of the study and such
recommendations as the President considers appropriate.
(d) Demand Reduction.--In this section, the term ``demand
reduction'' has the meaning provided in section 702(1) of the Office of
National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C.
1701(1)).
SEC. 1115. REPORT ON TRIBAL GOVERNMENT PARTICIPATION IN HIDTA PROCESS.
(a) Report Requirement.--The Director of the Office of National
Drug Control Policy shall prepare a report for Congress on the
representation of tribal governments in the High Intensity Drug
Trafficking Areas Program and in high intensity drug trafficking areas
designated under that Program. The report shall include--
(1) a list of the tribal governments represented in the Program
and a description of the participation by such governments in the
Program;
(2) an explanation of the rationale for the level of
representation by such governments; and
(3) recommendations by the Director for methods for increasing
the number of tribal governments represented in the Program.
(b) Deadline.--The report prepared under subsection (a) shall be
submitted not later than 1 year after the date of the enactment of this
Act.
(c) Definition.--In this section, the term ``High Intensity Drug
Trafficking Areas Program'' means the program established under section
707 of the Office of National Drug Control Policy Reauthorization Act
of 1998 (21 U.S.C. 1706)
SEC. 1116. REPORT ON SCHOOL DRUG TESTING.
(a) Report Requirement.--The Director of National Drug Control
Policy shall prepare a report on drug testing in schools. The report
shall include a list of secondary schools that have initiated drug
testing from among those schools that have attended conferences on drug
testing sponsored by the Office of National Drug Control Policy.
(b) Deadline.--Not later than 120 days after the date of the
enactment of this Act, the Director of National Drug Control Policy
shall submit to Congress the report required under subsection (a).
SEC. 1117. REPORT ON ONDCP PERFORMANCE BONUSES.
(a) Report Requirement.--The Director of National Drug Control
Policy shall prepare a report on performance bonuses at the Office of
National Drug Control Policy. The report shall include a list of
employees who received performance bonuses, and the amount of such
bonuses, for the period beginning on October 1, 2004, and ending on the
date of submission of the report.
(b) Deadline.--Not later than 120 days after the date of the
enactment of this Act, the Director of National Drug Control Policy
shall submit to Congress the report required under subsection (a).
SEC. 1118. REQUIREMENT FOR DISCLOSURE OF FEDERAL SPONSORSHIP OF ALL
FEDERAL ADVERTISING OR OTHER COMMUNICATION MATERIALS.
Section 712 is amended to read as follows:
``SEC. 712. REQUIREMENT FOR DISCLOSURE OF FEDERAL SPONSORSHIP OF
ALL FEDERAL ADVERTISING OR OTHER COMMUNICATION MATERIALS.
``(a) Requirement.--Each advertisement or other communication paid
for by the Office, either directly or through a contract awarded by the
Office, shall include a prominent notice informing the target audience
that the advertisement or other communication is paid for by the
Office.
``(b) Advertisement or Other Communication.--In this section, the
term `advertisement or other communication' includes--
``(1) an advertisement disseminated in any form, including
print or by any electronic means; and
``(2) a communication by an individual in any form, including
speech, print, or by any electronic means.''.
SEC. 1119. AWARDS FOR DEMONSTRATION PROGRAMS BY LOCAL PARTNERSHIPS TO
COERCE ABSTINENCE IN CHRONIC HARD-DRUG USERS UNDER COMMUNITY
SUPERVISION THROUGH THE USE OF DRUG TESTING AND SANCTIONS.
At the end of the Act, insert the following:
``SEC. 716. AWARDS FOR DEMONSTRATION PROGRAMS BY LOCAL PARTNERSHIPS
TO COERCE ABSTINENCE IN CHRONIC HARD-DRUG USERS UNDER COMMUNITY
SUPERVISION THROUGH THE USE OF DRUG TESTING AND SANCTIONS.
``(a) Awards Required.--The Director shall make competitive awards
to fund demonstration programs by eligible partnerships for the purpose
of reducing the use of illicit drugs by chronic hard-drug users living
in the community while under the supervision of the criminal justice
system.
``(b) Use of Award Amounts.--Award amounts received under this
section shall be used--
``(1) to support the efforts of the agencies, organizations,
and researchers included in the eligible partnership;
``(2) to develop and field a drug testing and graduated
sanctions program for chronic hard-drug users living in the
community under criminal justice supervision; and
``(3) to assist individuals described in subsection (a) by
strengthening rehabilitation efforts through such means as job
training, drug treatment, or other services.
``(c) Eligible Partnership Defined.--In this section, the term
`eligible partnership' means a working group whose application to the
Director--
``(1) identifies the roles played, and certifies the
involvement of, two or more agencies or organizations, which may
include--
``(A) State, local, or tribal agencies (such as those
carrying out police, probation, prosecution, courts,
corrections, parole, or treatment functions);
``(B) Federal agencies (such as the Drug Enforcement
Agency, the Bureau of Alcohol, Tobacco, Firearms, and
Explosives, and United States Attorney offices); and
``(C) community-based organizations;
``(2) includes a qualified researcher;
``(3) includes a plan for using judicial or other criminal
justice authority to administer drug tests to individuals described
in subsection (a) at least twice a week, and to swiftly and
certainly impose a known set of graduated sanctions for non-
compliance with community-release provisions relating to drug
abstinence (whether imposed as a pre-trial, probation, or parole
condition or otherwise);
``(4) includes a strategy for responding to a range of
substance use and abuse problems and a range of criminal histories;
``(5) includes a plan for integrating data infrastructure among
the agencies and organizations included in the eligible partnership
to enable seamless, real-time tracking of individuals described in
subsection (a);
``(6) includes a plan to monitor and measure the progress
toward reducing the percentage of the population of individuals
described in subsection (a) who, upon being summoned for a drug
test, either fail to show up or who test positive for drugs.
``(d) Reports to Congress.--
``(1) Interim report.--Not later than June 1, 2009, the
Director shall submit to Congress a report that identifies the best
practices in reducing the use of illicit drugs by chronic hard-drug
users, including the best practices identified through the
activities funded under this section.
``(2) Final report.--Not later than June 1, 2010, the Director
shall submit to Congress a report on the demonstration programs
funded under this section, including on the matters specified in
paragraph (1).
``(e) Authorization of Appropriations.--There is authorized to be
appropriated to carry out this section $4,900,000 for each of fiscal
years 2007 through 2009.''.
SEC. 1120. POLICY RELATING TO SYRINGE EXCHANGE PROGRAMS.
Section 703(a) (21 U.S.C. 1702(a)) is amended by adding at the end
the following:
``When developing the national drug control policy, any policy of the
Director relating to syringe exchange programs for intravenous drug
users shall be based on the best available medical and scientific
evidence regarding their effectiveness in promoting individual health
and preventing the spread of infectious disease, and their impact on
drug addiction and use. In making any policy relating to syringe
exchange programs, the Director shall consult with the National
Institutes of Health and the National Academy of Sciences.''.
Speaker of the House of Representatives.
Vice President of the United States and
President of the Senate.